[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[S. 2560 Reported in Senate (RS)]







                                                       Calendar No. 452
109th CONGRESS
  2d Session
                                S. 2560

       To reauthorize the Office of National Drug Control Policy.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             April 6, 2006

 Mr. Specter (for himself, Mr. Biden, Mr. Hatch, Mr. Grassley, and Mr. 
Levin) introduced the following bill; which was read twice and referred 
                   to the Committee on the Judiciary

                              May 25, 2006

               Reported by Mr. Specter, with an amendment
 [Strike out all after the enacting clause and insert the part printed 
                               in italic]

_______________________________________________________________________

                                 A BILL


 
       To reauthorize the Office of National Drug Control Policy.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

<DELETED>SECTION 1. SHORT TITLE, REFERENCE, AND TABLE OF 
              CONTENTS.</DELETED>

<DELETED>    (a) Short Title.--This Act may be cited as the ``Office of 
National Drug Control Policy Reauthorization Act of 2006''.</DELETED>
<DELETED>    (b) Amendment of Office of National Drug Control Policy 
Reauthorization Act of 1998.--Except as otherwise expressly provided, 
whenever in this Act an amendment or repeal is expressed in terms of an 
amendment to, or repeal of, a section or other provision, the reference 
shall be considered to be made to a section or other provision of the 
Office of National Drug Control Policy Reauthorization Act of 1998 
(Public Law 105-277; 21 U.S.C. 1701 et seq.).</DELETED>
<DELETED>    (c) Table of Contents.--The table of contents for this Act 
is as follows:</DELETED>

<DELETED>Sec. 1. Short title, reference, and table of contents.
   <DELETED>TITLE I--ORGANIZATION OF OFFICE OF NATIONAL DRUG CONTROL 
                 POLICY AND ROLES AND RESPONSIBILITIES

<DELETED>Sec. 101. Amendments to definitions.
<DELETED>Sec. 102. Establishment of the Office of National Drug Control 
                            Policy.
<DELETED>Sec. 103. Appointment and responsibilities of the Director.
<DELETED>Sec. 104. Amendments to ensure coordination with other 
                            agencies.
         <DELETED>TITLE II--THE NATIONAL DRUG CONTROL STRATEGY

<DELETED>Sec. 201. Annual preparation and submission of National Drug 
                            Control Strategy.
<DELETED>Sec. 202. Performance measurements.
<DELETED>Sec. 203. Annual report requirement.
       <DELETED>TITLE III--HIGH INTENSITY DRUG TRAFFICKING AREAS

<DELETED>Sec. 301. High Intensity Drug Trafficking Areas Program.
<DELETED>Sec. 302. Funding for certain high intensity drug trafficking 
                            areas.
<DELETED>Sec. 303. Assessment.
                     <DELETED>TITLE IV--TECHNOLOGY

<DELETED>Sec. 401. Counterdrug Technology Assessment Center.
<DELETED>TITLE V--REAUTHORIZATION AND IMPROVEMENT OF THE NATIONAL ANTI-
                          DRUG MEDIA CAMPAIGN

<DELETED>Sec. 501. Short title.
<DELETED>Sec. 502. Purposes of the National Youth Anti-Drug Media 
                            Campaign.
<DELETED>Sec. 503. Roles and responsibilities of the Director, the 
                            Partnership for a Drug-Free America, and a 
                            media buying contractor.
<DELETED>Sec. 504. Responsible use of Federal funds for the National 
                            Youth Anti-Drug Media Campaign.
<DELETED>Sec. 505. Authorization for National Youth Anti-Drug Media 
                            Campaign.
  <DELETED>TITLE VI--AUTHORIZATIONS AND EXTENSION OF TERMINATION DATE

<DELETED>Sec. 601. Authorization of appropriations.
<DELETED>Sec. 602. Extension of termination date.
                 <DELETED>TITLE VII--ANTI-DOPING AGENCY

<DELETED>Sec. 701. Designation of United States Anti-Doping Agency.
<DELETED>Sec. 702. Records, audit, and report.
<DELETED>Sec. 703. Authorization of appropriations.
               <DELETED>TITLE VIII--DRUG-FREE COMMUNITIES

<DELETED>Sec. 801. Reauthorization.
<DELETED>Sec. 802. Suspension of grants.
<DELETED>Sec. 803. Grant award increase.
<DELETED>Sec. 804. Prohibition on additional eligibility criteria.
<DELETED>Sec. 805. Supplemental grants for coalitions.
<DELETED>Sec. 806. National Community Antidrug Coalition Institute.
<DELETED>Sec. 807. Contracting requirement.
         <DELETED>TITLE IX--NATIONAL GUARD COUNTERDRUG SCHOOLS

<DELETED>Sec. 901. National Guard Counterdrug Schools.
               <DELETED>TITLE X--MISCELLANEOUS PROVISIONS

<DELETED>Sec. 1001. Repeals.
<DELETED>Sec. 1002. Controlled Substances Act amendments.
<DELETED>Sec. 1003. Report on intelligence sharing.
<DELETED>Sec. 1004. Requirement for South American heroin strategy.
<DELETED>Sec. 1005. Model Acts.

   <DELETED>TITLE I--ORGANIZATION OF OFFICE OF NATIONAL DRUG CONTROL 
            POLICY AND ROLES AND RESPONSIBILITIES</DELETED>

<DELETED>SEC. 101. AMENDMENTS TO DEFINITIONS.</DELETED>

<DELETED>    (a) Demand Reduction.--Section 702(1) is amended--
</DELETED>
        <DELETED>    (1) in subparagraph (F), by striking ``and'' after 
        the semicolon; and</DELETED>
        <DELETED>    (2) in subparagraph (G), by striking the period 
        and inserting ``; and''; and</DELETED>
        <DELETED>    (3) by adding at the end the following:</DELETED>
                <DELETED>    ``(H) international drug abuse education, 
                prevention, treatment, research, rehabilitation 
                activities, and interventions for drug abuse and 
                dependence.''.</DELETED>
<DELETED>    (b) Office.--Section 702(9) is amended by striking 
``implicates'' and inserting ``indicates''.</DELETED>
<DELETED>    (c) State and Local Affairs.--Paragraph (10) of section 
702 is amended to read as follows:</DELETED>
        <DELETED>    ``(10) State and local affairs.--The term `State 
        and local affairs' means domestic activities conducted by a 
        National Drug Control Program agency that are intended to 
        reduce the availability and use of illegal drugs, including--
        </DELETED>
                <DELETED>    ``(A) coordination and enhancement of 
                Federal, State, and local law enforcement drug control 
                efforts;</DELETED>
                <DELETED>    ``(B) coordination and enhancement of 
                efforts among National Drug Control Program agencies 
                and State and local demand reduction and supply 
                reduction agencies;</DELETED>
                <DELETED>    ``(C) coordination and enhancement of 
                Federal, State, and local law enforcement initiatives 
                to gather, analyze, and disseminate information and 
                intelligence relating to drug control among domestic 
                law enforcement agencies; and</DELETED>
                <DELETED>    ``(D) other coordinated and joint 
                initiatives among Federal, State, and local agencies to 
                promote comprehensive drug control strategies designed 
                to reduce the demand for, and the availability of, 
                illegal drugs.''.</DELETED>
<DELETED>    (d) Supply Reduction.--Section 702(11) is amended to read 
as follows:</DELETED>
        <DELETED>    ``(11) Supply reduction.--The term `supply 
        reduction' means any activity or program conducted by a 
        National Drug Control Program agency that is intended to reduce 
        the availability or use of illegal drugs in the United States 
        or abroad, including--</DELETED>
                <DELETED>    ``(A) activities to control international 
                trafficking in, and availability of, illegal drugs, 
                including--</DELETED>
                        <DELETED>    ``(i) accurate assessment and 
                        monitoring of international drug production and 
                        interdiction programs and policies; 
                        and</DELETED>
                        <DELETED>    ``(ii) coordination and promotion 
                        of compliance with international treaties 
                        relating to the production, transportation, or 
                        interdiction of illegal drugs;</DELETED>
                <DELETED>    ``(B) activities to conduct and promote 
                international law enforcement programs and policies to 
                reduce the supply of drugs; and</DELETED>
                <DELETED>    ``(C) activities to facilitate and enhance 
                the sharing of domestic and foreign intelligence 
                information among National Drug Control Program 
                agencies, relating to the production and trafficking of 
                drugs in the United States and in foreign 
                countries.''.</DELETED>
<DELETED>    (e) Definition of Appropriate Congressional Committees.--
Section 702 is amended by adding at the end the following:</DELETED>
        <DELETED>    ``(12) Appropriate congressional committees.--
        Except where otherwise provided, the term `appropriate 
        congressional committees' means the Committee on the Judiciary, 
        the Committee on Appropriations, and the Caucus on 
        International Narcotics Control of the Senate and the Committee 
        on Government Reform, the Committee on the Judiciary, and the 
        Committee on Appropriations of the House of 
        Representatives.''.</DELETED>

<DELETED>SEC. 102. ESTABLISHMENT OF THE OFFICE OF NATIONAL DRUG CONTROL 
              POLICY.</DELETED>

<DELETED>    (a) Responsibilities.--Section 703(a) is amended to read 
as follows:</DELETED>
<DELETED>    ``(a) Establishment of Office.--There is established in 
the Executive Office of the President an Office of National Drug 
Control Policy, which shall--</DELETED>
        <DELETED>    ``(1) develop national drug control 
        policy;</DELETED>
        <DELETED>    ``(2) coordinate and oversee the implementation of 
        the national drug control policy;</DELETED>
        <DELETED>    ``(3) assess and certify the adequacy of National 
        Drug Control Programs and the budget for those 
        programs;</DELETED>
        <DELETED>    ``(4) evaluate the effectiveness of National Drug 
        Control Program agencies' programs; and</DELETED>
        <DELETED>    ``(5) develop specific goals and performance 
        measurements needed to assess the effectiveness of--</DELETED>
                <DELETED>    ``(A) the national drug control policy; 
                and</DELETED>
                <DELETED>    ``(B) the programs of the National Drug 
                Control Program agencies.''.</DELETED>
<DELETED>    (b) Positions.--Section 703(b) is amended to read as 
follows:</DELETED>
<DELETED>    ``(b) Director of National Drug Control Policy and Deputy 
Directors.--</DELETED>
        <DELETED>    ``(1) Director.--There shall be a Director of 
        National Drug Control Policy who shall head the Office 
        (referred to in this Act as the `Director').</DELETED>
        <DELETED>    ``(2) Deputy director.--There shall be a Deputy 
        Director of National Drug Control Policy who shall report 
        directly to the Director (referred to in this Act as the 
        `Deputy Director').</DELETED>
        <DELETED>    ``(3) Other deputy directors.--</DELETED>
                <DELETED>    ``(A) In general.--There shall be a Deputy 
                Director for Demand Reduction, a Deputy Director for 
                Supply Reduction, and a Deputy Director for State and 
                Local Affairs.</DELETED>
                <DELETED>    ``(B) Reporting.--The Deputy Director for 
                Demand Reduction, the Deputy Director for Supply 
                Reduction, and the Deputy Director for State and Local 
                Affairs shall report directly to the Deputy Director of 
                the Office of National Drug Control Policy.</DELETED>
                <DELETED>    ``(C) Deputy director for demand 
                reduction.--The Deputy Director for Demand Reduction 
                shall be responsible for the activities--</DELETED>
                        <DELETED>    ``(i) in subparagraphs (A) through 
                        (H) of section 702(l); and</DELETED>
                        <DELETED>    ``(ii) in section 709, the 
                        National Youth Anti-Drug Media Campaign 
                        Act.</DELETED>
                <DELETED>    ``(D) Deputy director for supply 
                reduction.--The Deputy Director for Supply Reduction 
                shall be responsible for the activities in 
                subparagraphs (A) through (C) in section 
                702(11).</DELETED>
                <DELETED>    ``(E) Deputy director for state and local 
                affairs.--The Deputy Director for State and Local 
                Affairs shall be responsible for the activities--
                </DELETED>
                        <DELETED>    ``(i) in subparagraphs (A) through 
                        (D) of section 702(10);</DELETED>
                        <DELETED>    ``(ii) in section 707, the High 
                        Intensity Drug Trafficking Areas Program; 
                        and</DELETED>
                        <DELETED>    ``(iii) in section 708, the 
                        Counterdrug Technology Assessment 
                        Center.''.</DELETED>

<DELETED>SEC. 103. APPOINTMENT AND RESPONSIBILITIES OF THE 
              DIRECTOR.</DELETED>

<DELETED>    (a) Succession.--Section 704(a) is amended by amending 
paragraph (3) to read as follows:</DELETED>
        <DELETED>    ``(3) Acting director.--If the Director dies, 
        resigns, or is otherwise unable to perform the functions and 
        duties of the office, the Deputy Director shall perform the 
        functions and duties of the Director temporarily in an acting 
        capacity pursuant to subchapter III of chapter 33 of title 5, 
        United States Code.''.</DELETED>
<DELETED>    (b) Responsibilities.--Section 704(b) is amended--
</DELETED>
        <DELETED>    (1) in paragraph (4), by striking ``Federal 
        departments and agencies engaged in drug enforcement'' and 
        inserting ``National Drug Control Program agencies'';</DELETED>
        <DELETED>    (2) in paragraph (7), by inserting after 
        ``President'' the following: ``and the appropriate 
        congressional committees'';</DELETED>
        <DELETED>    (3) in paragraph (13), by striking ``(beginning in 
        1999)'';</DELETED>
        <DELETED>    (4) by striking paragraph (14) and inserting the 
        following:</DELETED>
        <DELETED>    ``(14) shall submit to the appropriate 
        congressional committees on an annual basis, not later than 60 
        days after the date of the last day of the applicable period, a 
        summary of--</DELETED>
                <DELETED>    ``(A) each of the evaluations received by 
                the Director under paragraph (13); and</DELETED>
                <DELETED>    ``(B) the progress of each National Drug 
                Control Program agency toward the drug control program 
                goals of the agency using the performance measures for 
                the agency developed under section 706(c);'';</DELETED>
        <DELETED>    (5) in paragraph (15), by striking subparagraph 
        (C) and inserting the following:</DELETED>
                <DELETED>    ``(C) supporting the substance abuse 
                information clearinghouse administered by the 
                Administrator of the Substance Abuse and Mental Health 
                Services Administration and established in section 
                501(d)(16) of the Public Health Service Act by--
                </DELETED>
                        <DELETED>    ``(i) encouraging all National 
                        Drug Control Program agencies to provide all 
                        appropriate and relevant information; 
                        and</DELETED>
                        <DELETED>    ``(ii) supporting the 
                        dissemination of information to all interested 
                        entities;''; and</DELETED>
        <DELETED>    (6) by inserting at the end the 
        following:</DELETED>
        <DELETED>    ``(16) shall coordinate with the private sector to 
        promote private research and development of medications to 
        treat addiction;</DELETED>
        <DELETED>    ``(17) shall seek the support and commitment of 
        State and local officials in the formulation and implementation 
        of the National Drug Control Strategy;</DELETED>
        <DELETED>    ``(18) shall monitor and evaluate the allocation 
        of resources among Federal law enforcement agencies in response 
        to significant local and regional drug trafficking and 
        production threats; and</DELETED>
        <DELETED>    ``(19) shall submit an annual report to Congress 
        detailing how the Office of National Drug Control Policy has 
        consulted with and assisted State and local governments with 
        respect to the formulation and implementation of the National 
        Drug Control Strategy and other relevant issues.''.</DELETED>
<DELETED>    (c) Review and Certification of National Drug Control 
Program Budget.--Section 704(c)(3) is amended--</DELETED>
        <DELETED>    (1) in subparagraph (C)(iii), by inserting ``and 
        the appropriate congressional committees,'' after ``House of 
        Representatives''; and</DELETED>
        <DELETED>    (2) in subparagraph (D)(ii)(II)(bb), by inserting 
        ``and the appropriate congressional committees,'' after ``House 
        of Representatives''.</DELETED>
<DELETED>    (d) Powers of Director.--Section 704(d) is amended--
</DELETED>
        <DELETED>    (1) in paragraph (9)--</DELETED>
                <DELETED>    (A) by inserting ``notwithstanding any 
                other provision of law,'' after ``(9)''; and</DELETED>
                <DELETED>    (B) by striking ``Strategy; and'' and 
                inserting ``Strategy and notify the appropriate 
                congressional committees of any fund control notice 
                issued in accordance with section 704(f)(5);''; 
                and</DELETED>
        <DELETED>    (2) in paragraph (10), by inserting before the 
        period the following: ``and section 706 of the Department of 
        State Authorization Act for Fiscal Year 2003 (22 U.S.C. 229j-
        1)''.</DELETED>
<DELETED>    (e) Fund Control Notices.--Section 704(f) is amended by 
adding at the end the following:</DELETED>
        <DELETED>    ``(4) Congressional notice.--A copy of each fund 
        control notice shall be transmitted to the appropriate 
        congressional committees.</DELETED>
        <DELETED>    ``(5) Restrictions.--The Director shall not issue 
        a fund control notice to direct that all or part of an amount 
        appropriated to the National Drug Control Program agency 
        account be obligated, modified, or altered in any manner--
        </DELETED>
                <DELETED>    ``(A) contrary, in whole or in part, to a 
                specific appropriation; or</DELETED>
                <DELETED>    ``(B) contrary, in whole or in part, to 
                the expressed intent of Congress.''.</DELETED>
<DELETED>    (f) United States Interdiction Coordinator.--</DELETED>
        <DELETED>    (1) In general.--Section 704 is amended by adding 
        at the end the following:</DELETED>
<DELETED>    ``(i) United States Interdiction Coordinator.--</DELETED>
        <DELETED>    ``(1) In general.--There shall be a United States 
        Interdiction Coordinator, who shall be designated by the 
        Director and who shall be responsible for the coordination of 
        interdiction operations among National Drug Control Program 
        agencies to prevent and reduce the illegal importation of drugs 
        into the United States.</DELETED>
        <DELETED>    ``(2) Responsibilities.--The United States 
        Interdiction Coordinator shall be responsible to the Director 
        for--</DELETED>
                <DELETED>    ``(A) coordinating the interdiction 
                activities of the National Drug Control Program 
                agencies to ensure consistency with the National Drug 
                Control Strategy;</DELETED>
                <DELETED>    ``(B) developing a National Drug Control 
                Interdiction plan to ensure consistency with the 
                National Drug Control Strategy;</DELETED>
                <DELETED>    ``(C) assessing the sufficiency of assets 
                of the National Drug Control Program agencies committed 
                to illicit drug interdiction; and</DELETED>
                <DELETED>    ``(D) advising the Director on the efforts 
                of each National Drug Control Program Agency to 
                implement the National Drug Control Interdiction 
                plan.''.</DELETED>
        <DELETED>    (2) Amendment to homeland security act of 2002.--
        Section 878 of the Homeland Security Act of 2002 (6 U.S.C. 458) 
        is amended by striking ``shall--'' through paragraph (2) and 
        inserting ``shall ensure the adequacy of resources within the 
        Department for illicit drug interdiction.''.</DELETED>

<DELETED>SEC. 104. AMENDMENTS TO ENSURE COORDINATION WITH OTHER 
              AGENCIES.</DELETED>

<DELETED>    Section 705 is amended--</DELETED>
        <DELETED>    (1) in subsection (a)(1)(A), by striking 
        ``abuse'';</DELETED>
        <DELETED>    (2) by amending subsection (a)(3) to read as 
        follows:</DELETED>
        <DELETED>    ``(3) Required reports.--</DELETED>
                <DELETED>    ``(A) Secretaries of the interior and 
                agriculture.--Not later than July 1 of each year, the 
                Secretaries of Agriculture and the Interior shall 
                jointly submit to the Director and the appropriate 
                congressional committees an assessment of the quantity 
                of illegal drug cultivation and manufacturing in the 
                United States on lands owned or under the jurisdiction 
                of the Federal Government for the preceding 
                year.</DELETED>
                <DELETED>    ``(B) Secretary of homeland security.--Not 
                later than July 1 of each year, the Secretary of 
                Homeland Security shall submit to the Director and the 
                appropriate congressional committees information for 
                the preceding year regarding--</DELETED>
                        <DELETED>    ``(i) the number and type of 
                        seizures of drugs by each component of the 
                        Department of Homeland Security seizing drugs, 
                        as well as statistical information on the 
                        geographic areas of such seizures; 
                        and</DELETED>
                        <DELETED>    ``(ii) the number of air and 
                        maritime patrol hours primarily dedicated to 
                        drug supply reduction missions undertaken by 
                        each component of the Department of Homeland 
                        Security.</DELETED>
                <DELETED>    ``(C) Secretary of defense.--The Secretary 
                of Defense shall, by July 1 of each year, submit to the 
                Director and the appropriate congressional committees 
                information for the preceding year regarding the number 
                of air and maritime patrol hours primarily dedicated to 
                drug supply reduction missions undertaken by each 
                component of the Department of Defense.''; 
                and</DELETED>
        <DELETED>    (3) in subsection (b)(2)(B), by striking 
        ``Program'' and inserting ``Strategy''.</DELETED>

    <DELETED>TITLE II--THE NATIONAL DRUG CONTROL STRATEGY</DELETED>

<DELETED>SEC. 201. ANNUAL PREPARATION AND SUBMISSION OF NATIONAL DRUG 
              CONTROL STRATEGY.</DELETED>

<DELETED>    Section 706 is amended to read as follows:</DELETED>

<DELETED>``SEC. 706. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, AND 
              ASSESSMENT OF NATIONAL DRUG CONTROL STRATEGY.</DELETED>

<DELETED>    ``(a) Timing, Contents, and Process for Development and 
Submission of National Drug Control Strategy.--</DELETED>
        <DELETED>    ``(1) Timing.--Not later than February 1 of each 
        year, the President shall submit to Congress a National Drug 
        Control Strategy, which shall set forth a comprehensive plan 
        for the year to reduce drug abuse and the consequences of such 
        drug abuse in the United States by limiting the availability 
        of, and reducing the demand for, illegal drugs.</DELETED>
        <DELETED>    ``(2) Contents.--</DELETED>
                <DELETED>    ``(A) In general.--The National Drug 
                Control Strategy submitted under paragraph (1) shall 
                include--</DELETED>
                        <DELETED>    ``(i) comprehensive, research-
                        based, long-range, quantifiable goals for 
                        reducing drug abuse and the consequences of 
                        drug abuse in the United States;</DELETED>
                        <DELETED>    ``(ii) annual quantifiable and 
                        measurable objectives and specific targets to 
                        accomplish long-term quantifiable goals that 
                        the Director determines may be achieved during 
                        each year beginning on the date on which the 
                        National Drug Control Strategy is 
                        submitted;</DELETED>
                        <DELETED>    ``(iii) 5-year projections for 
                        program and budget priorities;</DELETED>
                        <DELETED>    ``(iv) a review of international, 
                        State, local, and private sector drug control 
                        activities to ensure that the United States 
                        pursues coordinated and effective drug control 
                        at all levels of government;</DELETED>
                        <DELETED>    ``(v) an assessment of current 
                        illicit drug use (including inhalants) and 
                        availability, impact of illicit drug use, and 
                        treatment availability, which assessment shall 
                        include--</DELETED>
                                <DELETED>    ``(I) estimates of drug 
                                prevalence and frequency of use as 
                                measured by national, State, and local 
                                surveys of illicit drug use and by 
                                other special studies of nondependent 
                                and dependent illicit drug 
                                use;</DELETED>
                                <DELETED>    ``(II) illicit drug use in 
                                the workplace and the productivity lost 
                                by such use; and</DELETED>
                                <DELETED>    ``(III) illicit drug use 
                                by arrestees, probationers, and 
                                parolees;</DELETED>
                        <DELETED>    ``(vi) an assessment of the 
                        reduction of illicit drug availability, as 
                        measured by--</DELETED>
                                <DELETED>    ``(I) the quantities of 
                                cocaine, heroin, marijuana, 
                                methamphetamine, ecstasy, and other 
                                drugs available for consumption in the 
                                United States;</DELETED>
                                <DELETED>    ``(II) the amount of 
                                marijuana, cocaine, heroin, 
                                methamphetamine, ecstasy, and precursor 
                                chemicals and other drugs entering the 
                                United States;</DELETED>
                                <DELETED>    ``(III) the number of 
                                illicit drug manufacturing laboratories 
                                seized and destroyed and the number of 
                                hectares of marijuana, poppy, and coca 
                                cultivated and destroyed domestically 
                                and in other countries;</DELETED>
                                <DELETED>    ``(IV) the number of 
                                metric tons of marijuana, heroin, 
                                cocaine, and methamphetamine seized and 
                                other drugs; and</DELETED>
                                <DELETED>    ``(V) changes in the price 
                                and purity of heroin, methamphetamine, 
                                and cocaine, changes in the price of 
                                ecstasy, and changes in 
                                tetrahydrocannabinol level of marijuana 
                                and other drugs;</DELETED>
                        <DELETED>    ``(vii) an assessment of the 
                        reduction of the consequences of illicit drug 
                        use and availability, which shall include--
                        </DELETED>
                                <DELETED>    ``(I) the burden illicit 
                                drug users placed on hospital emergency 
                                departments in the United States, such 
                                as the quantity of illicit drug-related 
                                services provided;</DELETED>
                                <DELETED>    ``(II) the annual national 
                                health care cost of illicit drug use; 
                                and</DELETED>
                                <DELETED>    ``(III) the extent of 
                                illicit drug-related crime and criminal 
                                activity;</DELETED>
                        <DELETED>    ``(viii) a determination of the 
                        status of drug treatment in the United States, 
                        by assessing--</DELETED>
                                <DELETED>    ``(I) public and private 
                                treatment utilization; and</DELETED>
                                <DELETED>    ``(II) the number of 
                                illicit drug users the Director 
                                estimates meet diagnostic criteria for 
                                treatment;</DELETED>
                        <DELETED>    ``(ix) a review of the research 
                        agenda of the Counterdrug Technology Assessment 
                        Center to reduce the availability and abuse of 
                        drugs; and</DELETED>
                        <DELETED>    ``(x) a summary of the efforts 
                        made to coordinate with private sector entities 
                        to conduct private research and development of 
                        medications to treat addiction by--</DELETED>
                                <DELETED>    ``(I) screening chemicals 
                                for potential therapeutic 
                                value;</DELETED>
                                <DELETED>    ``(II) developing 
                                promising compounds;</DELETED>
                                <DELETED>    ``(III) conducting 
                                clinical trials;</DELETED>
                                <DELETED>    ``(IV) seeking Food and 
                                Drug Administration approval for drugs 
                                to treat addiction;</DELETED>
                                <DELETED>    ``(V) marketing the drug 
                                for the treatment of 
                                addiction;</DELETED>
                                <DELETED>    ``(VI) urging physicians 
                                to use the drug in the treatment of 
                                addiction; and</DELETED>
                                <DELETED>    ``(VII) encouraging 
                                insurance companies to reimburse the 
                                cost of the drug for the treatment of 
                                addiction.</DELETED>
                <DELETED>    ``(B) Classified information.--Any 
                contents of the National Drug Control Strategy that 
                involve information properly classified under criteria 
                established by an Executive order shall be presented to 
                Congress separately from the rest of the National Drug 
                Control Strategy.</DELETED>
        <DELETED>    ``(3) Process for development and submission.--In 
        developing and effectively implementing the National Drug 
        Control Strategy, the Director--</DELETED>
                <DELETED>    ``(A) shall consult with--</DELETED>
                        <DELETED>    ``(i) the heads of the National 
                        Drug Control Program agencies;</DELETED>
                        <DELETED>    ``(ii) Congress;</DELETED>
                        <DELETED>    ``(iii) State and local 
                        officials;</DELETED>
                        <DELETED>    ``(iv) private citizens and 
                        organizations with experience and expertise in 
                        demand reduction;</DELETED>
                        <DELETED>    ``(v) private citizens and 
                        organizations with experience and expertise in 
                        supply reduction; and</DELETED>
                        <DELETED>    ``(vi) appropriate representatives 
                        of foreign governments;</DELETED>
                <DELETED>    ``(B) in satisfying the requirements of 
                subparagraph (A), shall ensure, to the maximum extent 
                possible, that State and local officials and relevant 
                private organizations commit to support and take steps 
                to achieve the goals and objectives of the National 
                Drug Control Strategy;</DELETED>
                <DELETED>    ``(C) with the concurrence of the Attorney 
                General, may require the El Paso Intelligence Center to 
                undertake specific tasks or projects to support or 
                implement the National Drug Control Strategy; 
                and</DELETED>
                <DELETED>    ``(D) with the concurrence of the Director 
                of National Intelligence and the Attorney General, may 
                request that the National Drug Intelligence Center 
                undertake specific tasks or projects to support or 
                implement the National Drug Control Strategy.</DELETED>
<DELETED>    ``(b) Submission of Revised Strategy.--The President may 
submit to Congress a revised National Drug Control Strategy that meets 
the requirements of this section--</DELETED>
        <DELETED>    ``(1) at any time, upon a determination of the 
        President, in consultation with the Director, that the National 
        Drug Control Strategy in effect is not sufficiently effective; 
        or</DELETED>
        <DELETED>    ``(2) if a new President or Director takes 
        office.''.</DELETED>

<DELETED>SEC. 202. PERFORMANCE MEASUREMENTS.</DELETED>

<DELETED>    Section 706 is amended by adding at the end the 
following:</DELETED>
<DELETED>    ``(c) Performance Measurement System.--Not later than 
February 1 of each year, the Director shall submit to Congress as part 
of the National Drug Control Strategy, a description of a national drug 
control performance measurement system, that--</DELETED>
        <DELETED>    ``(1) develops 2-year and 5-year performance 
        measures and targets for each National Drug Control Strategy 
        goal and objective established for reducing drug use, 
        availability, and the consequences of drug use;</DELETED>
        <DELETED>    ``(2) describes the sources of information and 
        data that will be used for each performance measure 
        incorporated into the performance measurement system;</DELETED>
        <DELETED>    ``(3) identifies major programs and activities of 
        the National Drug Control Program agencies that support the 
        goals and annual objectives of the National Drug Control 
        Strategy;</DELETED>
        <DELETED>    ``(4) evaluates the contribution of demand 
        reduction and supply reduction activities as defined in section 
        702 implemented by each National Drug Control Program agency in 
        support of the National Drug Control Strategy;</DELETED>
        <DELETED>    ``(5) monitors consistency between the drug-
        related goals and objectives of the National Drug Control 
        Program agencies and ensures that each agency's goals and 
        budgets support and are fully consistent with the National Drug 
        Control Strategy; and</DELETED>
        <DELETED>    ``(6) coordinates the development and 
        implementation of national drug control data collection and 
        reporting systems to support policy formulation and performance 
        measurement, including an assessment of--</DELETED>
                <DELETED>    ``(A) the quality of current drug use 
                measurement instruments and techniques to measure 
                supply reduction and demand reduction 
                activities;</DELETED>
                <DELETED>    ``(B) the adequacy of the coverage of 
                existing national drug use measurement instruments and 
                techniques to measure the casual drug use population, 
                the addicted drug user population, and groups that are 
                at risk for drug use;</DELETED>
                <DELETED>    ``(C) the adequacy of the coverage of 
                existing national treatment outcome monitoring systems 
                to measure the effectiveness of drug abuse treatment in 
                reducing drug use and criminal behavior during and 
                after the completion of substance abuse treatment; 
                and</DELETED>
                <DELETED>    ``(D) the actions the Director shall take 
                to correct any deficiencies and limitations identified 
                pursuant to subparagraphs (A) and (B) of this 
                subsection.</DELETED>
<DELETED>    ``(d) Modifications.--A description of any modifications 
made during the preceding year to the national drug performance 
measurement system described in subsection (c) shall be included in 
each report submitted under subsection (b).''.</DELETED>

<DELETED>SEC. 203. ANNUAL REPORT REQUIREMENT.</DELETED>

<DELETED>    (a) In General.--On or before February 1 of each year, the 
Director shall submit a report to Congress that describes--</DELETED>
        <DELETED>    (1) the strategy of the national media campaign 
        and whether specific objectives of the campaign were 
        accomplished;</DELETED>
        <DELETED>    (2) steps taken to ensure that the national media 
        campaign operates in an effective and efficient manner 
        consistent with the overall strategy and focus of the 
        campaign;</DELETED>
        <DELETED>    (3) plans to purchase advertising time and 
        space;</DELETED>
        <DELETED>    (4) policies and practices implemented to ensure 
        that Federal funds are used responsibly to purchase advertising 
        time and space and eliminate the potential for waste, fraud, 
        and abuse;</DELETED>
        <DELETED>    (5) all contracts entered into with a corporation, 
        partnership, or individual working on behalf of the national 
        media campaign;</DELETED>
        <DELETED>    (6) specific policies and steps implemented to 
        ensure compliance with title IV of this Act;</DELETED>
        <DELETED>    (7) steps taken to ensure that the national media 
        campaign will secure, to the maximum extent possible, no cost 
        matches of advertising time and space or in-kind contributions 
        that are directly related to the campaign in accordance with 
        title IV of this Act; and</DELETED>
        <DELETED>    (8) a review and evaluation of the effectiveness 
        of the national media campaign strategy for the past 
        year.</DELETED>
<DELETED>    (b) Audit.--The Government Accountability Office shall, at 
a frequency of not less than once per year--</DELETED>
        <DELETED>    (1) conduct and supervise an audit and 
        investigation relating to the programs and operations of the--
        </DELETED>
                <DELETED>    (A) Office; or</DELETED>
                <DELETED>    (B) certain programs within the Office, 
                including--</DELETED>
                        <DELETED>    (i) the High Intensity Drug 
                        Trafficking Areas Program;</DELETED>
                        <DELETED>    (ii) the Counterdrug Technology 
                        Assessment Center; or</DELETED>
                        <DELETED>    (iii) the National Youth Anti-drug 
                        Media Campaign; and</DELETED>
        <DELETED>    (2) provide the Director and the appropriate 
        congressional committees with a report containing an evaluation 
        of and recommendations on the--</DELETED>
                <DELETED>    (A) policies and activities of the 
                programs and operations subject to the audit and 
                investigation;</DELETED>
                <DELETED>    (B) economy, efficiency, and effectiveness 
                in the administration of the reviewed programs and 
                operations; and</DELETED>
                <DELETED>    (C) policy or management changes needed to 
                prevent and detect fraud and abuse in such programs and 
                operations.</DELETED>

  <DELETED>TITLE III--HIGH INTENSITY DRUG TRAFFICKING AREAS</DELETED>

<DELETED>SEC. 301. HIGH INTENSITY DRUG TRAFFICKING AREAS 
              PROGRAM.</DELETED>

<DELETED>    Section 707 is amended to read as follows:</DELETED>

<DELETED>``SEC. 707. HIGH INTENSITY DRUG TRAFFICKING AREAS 
              PROGRAM.</DELETED>

<DELETED>    ``(a) Establishment.--</DELETED>
        <DELETED>    ``(1) In general.--There is established in the 
        Office a program to be known as the High Intensity Drug 
        Trafficking Areas Program (in this section referred to as the 
        `Program').</DELETED>
        <DELETED>    ``(2) Purpose.--The purpose of the Program is to 
        reduce drug trafficking and drug production in the United 
        States by--</DELETED>
                <DELETED>    ``(A) facilitating cooperation among 
                Federal, State, and local law enforcement agencies to 
                share information and implement coordinated enforcement 
                activities;</DELETED>
                <DELETED>    ``(B) enhancing intelligence sharing among 
                Federal, State, and local law enforcement 
                agencies;</DELETED>
                <DELETED>    ``(C) providing reliable intelligence to 
                law enforcement agencies needed to design effective 
                enforcement strategies and operations; and</DELETED>
                <DELETED>    ``(D) supporting coordinated law 
                enforcement strategies which maximize use of available 
                resources to reduce the supply of illegal drugs in 
                designated areas and in the United States as a 
                whole.</DELETED>
<DELETED>    ``(b) Designation.--</DELETED>
        <DELETED>    ``(1) In general.--The Director, in consultation 
        with the Attorney General, the Secretary of the Treasury, the 
        Secretary of Homeland Security, heads of the National Drug 
        Control Program agencies, and the Governor of each applicable 
        State, may designate any specified area of the United States as 
        a high intensity drug trafficking area.</DELETED>
        <DELETED>    ``(2) Activities.--After making a designation 
        under paragraph (1) and in order to provide Federal assistance 
        to the area so designated, the Director may--</DELETED>
                <DELETED>    ``(A) obligate such sums as are 
                appropriated for the Program;</DELETED>
                <DELETED>    ``(B) direct the temporary reassignment of 
                Federal personnel to such area, subject to the approval 
                of the head of the department or agency that employs 
                such personnel;</DELETED>
                <DELETED>    ``(C) take any other action authorized 
                under section 704 to provide increased Federal 
                assistance to those areas; and</DELETED>
                <DELETED>    ``(D) coordinate activities under this 
                section (specifically administrative, recordkeeping, 
                and funds management activities) with State and local 
                officials.</DELETED>
<DELETED>    ``(c) Petitions for Designation.--The Director shall 
establish regulations under which a coalition of interested law 
enforcement agencies from an area may petition for designation as a 
high intensity drug trafficking area. Such regulations shall provide 
for a regular review by the Director of the petition, including a 
recommendation regarding the merit of the petition to the Director by a 
panel of qualified, independent experts.</DELETED>
<DELETED>    ``(d) Factors for Consideration.--In considering whether 
to designate an area under this section as a high intensity drug 
trafficking area, the Director shall consider, in addition to such 
other criteria as the Director considers to be appropriate, the extent 
to which--</DELETED>
        <DELETED>    ``(1) the area is a significant center of illegal 
        drug production, manufacturing, importation, or 
        distribution;</DELETED>
        <DELETED>    ``(2) State and local law enforcement agencies 
        have committed resources to respond to the drug trafficking 
        problem in the area, thereby indicating a determination to 
        respond aggressively to the problem;</DELETED>
        <DELETED>    ``(3) drug-related activities in the area are 
        having a significant harmful impact in the area, and in other 
        areas of the country; and</DELETED>
        <DELETED>    ``(4) a significant increase in allocation of 
        Federal resources is necessary to respond adequately to drug-
        related activities in the area.</DELETED>
<DELETED>    ``(e) Organization of High Intensity Drug Trafficking 
Areas.--</DELETED>
        <DELETED>    ``(1) Executive board and officers.--To be 
        eligible for funds appropriated under this section, each high 
        intensity drug trafficking area shall be governed by an 
        Executive Board. The Executive Board shall designate a 
        chairman, vice chairman, and any other officers to the 
        Executive Board that it determines are necessary.</DELETED>
        <DELETED>    ``(2) Responsibilities.--The Executive Board of a 
        high intensity drug trafficking area shall be responsible for--
        </DELETED>
                <DELETED>    ``(A) providing direction and oversight in 
                establishing and achieving the goals of the high 
                intensity drug trafficking area;</DELETED>
                <DELETED>    ``(B) managing the funds of the high 
                intensity drug trafficking area;</DELETED>
                <DELETED>    ``(C) reviewing and approving all funding 
                proposals consistent with the overall objective of the 
                high intensity drug trafficking area; and</DELETED>
                <DELETED>    ``(D) reviewing and approving all reports 
                to the Director on the activities of the high intensity 
                drug trafficking area.</DELETED>
        <DELETED>    ``(3) Board representation.--None of the funds 
        appropriated under this section may be expended for any high 
        intensity drug trafficking area, or for a partnership or region 
        of a high intensity drug trafficking area, if the Executive 
        Board for such area, region, or partnership, does not apportion 
        an equal number of votes between representatives of 
        participating Federal agencies and representatives of 
        participating State and local agencies. Where it is impractical 
        for an equal number of representatives of Federal agencies and 
        State and local agencies to attend a meeting of an Executive 
        Board in person, the Executive Board may use a system of proxy 
        votes or weighted votes to achieve the voting balance required 
        by this paragraph.</DELETED>
        <DELETED>    ``(4) No agency relationship.--The eligibility 
        requirements of this section are intended to ensure the 
        responsible use of Federal funds. Nothing in this section is 
        intended to create an agency relationship between individual 
        high intensity drug trafficking areas and the Federal 
        Government.</DELETED>
<DELETED>    ``(f) Use of Funds.--The Director shall ensure that no 
Federal funds appropriated for the Program are expended for the 
establishment or expansion of drug treatment programs, and shall ensure 
that not more than 5 percent of the Federal funds appropriated for the 
Program are expended for the establishment of drug prevention 
programs.</DELETED>
<DELETED>    ``(g) Counterterrorism Activities.--</DELETED>
        <DELETED>    ``(1) Assistance authorized.--The Director may 
        authorize use of resources available for the Program to assist 
        Federal, State, and local law enforcement agencies in 
        investigations and activities related to terrorism and 
        prevention of terrorism, especially but not exclusively with 
        respect to such investigations and activities that are also 
        related to drug trafficking.</DELETED>
        <DELETED>    ``(2) Limitation.--The Director shall ensure--
        </DELETED>
                <DELETED>    ``(A) that assistance provided under 
                paragraph (1) remains incidental to the purpose of the 
                Program to reduce drug availability and carry out drug-
                related law enforcement activities; and</DELETED>
                <DELETED>    ``(B) that significant resources of the 
                Program are not redirected to activities exclusively 
                related to terrorism, except on a temporary basis under 
                extraordinary circumstances, as determined by the 
                Director.</DELETED>
<DELETED>    ``(h) Role of Drug Enforcement Administration.--The 
Director, in consultation with the Attorney General, shall ensure that 
a representative of the Drug Enforcement Administration is included in 
the Intelligence Support Center for each high intensity drug 
trafficking area.</DELETED>
<DELETED>    ``(i) Annual HIDTA Program Budget Submissions.--As part of 
the documentation that supports the President's annual budget request 
for the Office, the Director shall submit to Congress a budget 
justification that includes--</DELETED>
        <DELETED>    ``(1) the amount requested for each high intensity 
        drug trafficking area, with supporting narrative descriptions 
        and rationale for each request; and</DELETED>
        <DELETED>    ``(2) a detailed justification for each funding 
        request that explains--</DELETED>
                <DELETED>    ``(A) the reasons for the requested 
                funding level; how such funding level was determined 
                based on a current assessment of the drug trafficking 
                threat in each high intensity drug trafficking 
                area;</DELETED>
                <DELETED>    ``(B) how such funding will ensure that 
                the goals and objectives of each such area will be 
                achieved; and</DELETED>
                <DELETED>    ``(C) how such funding supports the 
                National Drug Control Strategy.</DELETED>
<DELETED>    ``(j) Emerging Threat Response Fund.--</DELETED>
        <DELETED>    ``(1) In general.--Subject to the availability of 
        appropriations, the Director may expend up to 10 percent of the 
        amounts appropriated under this section on a discretionary 
        basis, to respond to any emerging drug trafficking threat in an 
        existing high intensity drug trafficking area, or to establish 
        a new high intensity drug trafficking area or expand an 
        existing high intensity drug trafficking area, in accordance 
        with the criteria established under paragraph (2).</DELETED>
        <DELETED>    ``(2) Consideration of impact.--In allocating 
        funds under this subsection, the Director shall consider--
        </DELETED>
                <DELETED>    ``(A) the impact of activities funded on 
                reducing overall drug traffic in the United States, or 
                minimizing the probability that an emerging drug 
                trafficking threat will spread to other areas of the 
                United States; and</DELETED>
                <DELETED>    ``(B) such other criteria as the Director 
                considers appropriate.</DELETED>
<DELETED>    ``(k) Evaluation.--</DELETED>
        <DELETED>    ``(1) Initial report.--Not later than 90 days 
        after the date of the enactment of this section, the Director 
        shall, after consulting with the Executive Boards of each 
        designated high intensity drug trafficking area, submit a 
        report to Congress that describes, for each designated high 
        intensity drug trafficking area--</DELETED>
                <DELETED>    ``(A) the specific purposes for the high 
                intensity drug trafficking area;</DELETED>
                <DELETED>    ``(B) the specific long-term and short-
                term goals and objectives for the high intensity drug 
                trafficking area;</DELETED>
                <DELETED>    ``(C) the measurements that will be used 
                to evaluate the performance of the high intensity drug 
                trafficking area in achieving the long-term and short-
                term goals; and</DELETED>
                <DELETED>    ``(D) the reporting requirements needed to 
                evaluate the performance of the high intensity drug 
                trafficking area in achieving the long-term and short-
                term goals.</DELETED>
        <DELETED>    ``(2) Evaluation of hidta program as part of 
        national drug control strategy.--For each designated high 
        intensity drug trafficking area, the Director shall submit, as 
        part of the annual National Drug Control Strategy report, a 
        report that--</DELETED>
                <DELETED>    ``(A) describes--</DELETED>
                        <DELETED>    ``(i) the specific purposes for 
                        the high intensity drug trafficking area; 
                        and</DELETED>
                        <DELETED>    ``(ii) the specific long-term and 
                        short-term goals and objectives for the high 
                        intensity drug trafficking area; and</DELETED>
                <DELETED>    ``(B) includes an evaluation of the 
                performance of the high intensity drug trafficking area 
                in accomplishing the specific long-term and short-term 
                goals and objectives identified under paragraph 
                (1)(B).</DELETED>
<DELETED>    ``(l) Assessment of Drug Enforcement Task Forces in High 
Intensity Drug Trafficking Areas.--Not later than 180 days after the 
date of enactment of this subsection, and as part of each subsequent 
annual National Drug Control Strategy report, the Director shall submit 
to Congress a report--</DELETED>
        <DELETED>    ``(1) assessing the number and operation of all 
        federally funded drug enforcement task forces within each high 
        intensity drug trafficking area; and</DELETED>
        <DELETED>    ``(2) describing--</DELETED>
                <DELETED>    ``(A) each Federal, State, and local drug 
                enforcement task force operating in the high intensity 
                drug trafficking area;</DELETED>
                <DELETED>    ``(B) how such task forces coordinate with 
                each other, with any high intensity drug trafficking 
                area task force, and with investigations receiving 
                funds from the Organized Crime and Drug Enforcement 
                Task Force;</DELETED>
                <DELETED>    ``(C) what steps, if any, each such task 
                force takes to share information regarding drug 
                trafficking and drug production with other federally 
                funded drug enforcement task forces in the high 
                intensity drug trafficking area;</DELETED>
                <DELETED>    ``(D) the role of the high intensity drug 
                trafficking area in coordinating the sharing of such 
                information among task forces;</DELETED>
                <DELETED>    ``(E) the nature and extent of cooperation 
                by each Federal, State, and local participant in 
                ensuring that such information is shared among law 
                enforcement agencies and with the high intensity drug 
                trafficking area;</DELETED>
                <DELETED>    ``(F) the nature and extent to which 
                information sharing and enforcement activities are 
                coordinated with joint terrorism task forces in the 
                high intensity drug trafficking area; and</DELETED>
                <DELETED>    ``(G) any recommendations for measures 
                needed to ensure that task force resources are utilized 
                efficiently and effectively to reduce the availability 
                of illegal drugs in the high intensity drug trafficking 
                areas.</DELETED>
<DELETED>    ``(m) Assessment of Intelligence Sharing in High Intensity 
Drug Trafficking Areas Program.--Not later than 180 days after the date 
of the enactment of this section, and as part of each subsequent annual 
National Drug Control Strategy report, the Director, in consultation 
with the Director of National Intelligence, shall submit to Congress a 
report--</DELETED>
        <DELETED>    ``(1) evaluating existing and planned intelligence 
        systems supported by each high intensity drug trafficking area, 
        or utilized by task forces receiving any funding under the 
        Program, including the extent to which such systems ensure 
        access and availability of intelligence to Federal, State, and 
        local law enforcement agencies within the high intensity drug 
        trafficking area and outside of it;</DELETED>
        <DELETED>    ``(2) the extent to which Federal, State, and 
        local law enforcement agencies participating in each high 
        intensity drug trafficking area are sharing intelligence 
        information to assess current drug trafficking threats and 
        design appropriate enforcement strategies; and</DELETED>
        <DELETED>    ``(3) the measures needed to improve effective 
        sharing of information and intelligence regarding drug 
        trafficking and drug production among Federal, State, and local 
        law enforcement participating in a high intensity drug 
        trafficking area, and between such agencies and similar 
        agencies outside the high intensity drug trafficking 
        area.</DELETED>
<DELETED>    ``(n) Coordination of Intelligence Sharing With Organized 
Crime Drug Enforcement Task Force Program.--The Director, in 
consultation with the Attorney General, shall ensure that any drug 
enforcement intelligence obtained by the Intelligence Support Center 
for each high intensity drug trafficking area is shared, on a timely 
basis, with the drug intelligence fusion center operated by the 
Organized Crime Drug Enforcement Task Force of the Department of 
Justice.</DELETED>
<DELETED>    ``(o) Use of Funds to Combat Methamphetamine 
Trafficking.--</DELETED>
        <DELETED>    ``(1) In general.--</DELETED>
                <DELETED>    ``(A) Requirement.--The Director shall 
                ensure that, of the amounts appropriated for a fiscal 
                year for the Program, at least $15,000,000 is allocated 
                to combat the trafficking of methamphetamine in areas 
                designated by the Director as high intensity drug 
                trafficking areas.</DELETED>
                <DELETED>    ``(B) Activities.--In meeting the 
                requirement in subparagraph (A), the Director shall 
                transfer funds to appropriate Federal, State, and local 
                governmental agencies for employing additional Federal 
                law enforcement personnel, or facilitating the 
                employment of additional State and local law 
                enforcement personnel, including agents, investigators, 
                prosecutors, laboratory technicians, chemists, 
                investigative assistants, and drug prevention 
                specialists.</DELETED>
        <DELETED>    ``(2) Apportionment of funds.--</DELETED>
                <DELETED>    ``(A) Factors in apportionment.--The 
                Director shall apportion amounts allocated under 
                paragraph (1) among areas designated by the Director as 
                high intensity drug trafficking areas based on the 
                following factors:</DELETED>
                        <DELETED>    ``(i) The number of 
                        methamphetamine manufacturing facilities 
                        discovered by Federal, State, or local law 
                        enforcement officials in the area during the 
                        previous fiscal year.</DELETED>
                        <DELETED>    ``(ii) The number of 
                        methamphetamine prosecutions in Federal, State, 
                        or local courts in the area during the previous 
                        fiscal year.</DELETED>
                        <DELETED>    ``(iii) The number of 
                        methamphetamine arrests by Federal, State, or 
                        local law enforcement officials in the area 
                        during the previous fiscal year.</DELETED>
                        <DELETED>    ``(iv) The amounts of 
                        methamphetamine or listed chemicals (as that 
                        term is defined in section 102(33) of the 
                        Controlled Substances Act (21 U.S.C. 802(33)) 
                        seized by Federal, State, or local law 
                        enforcement officials in the area during the 
                        previous fiscal year.</DELETED>
                        <DELETED>    ``(v) Intelligence and predictive 
                        data from the Drug Enforcement Administration 
                        showing patterns and trends in abuse, 
                        trafficking, and transportation in 
                        methamphetamine and listed chemicals (as that 
                        term is so defined).</DELETED>
                <DELETED>    ``(B) Certification.--Before the Director 
                apportions any funds under this paragraph to a high 
                intensity drug trafficking area, the Director shall 
                certify that the law enforcement entities responsible 
                for clandestine methamphetamine laboratory seizures in 
                that area are providing laboratory seizure data to the 
                national clandestine laboratory database at the El Paso 
                Intelligence Center.</DELETED>
<DELETED>    ``(p) Authorization of Appropriations.--There is 
authorized to be appropriated to the Office of National Drug Control 
Policy to carry out this section--</DELETED>
        <DELETED>    ``(1) $280,000,000 for fiscal year 2007;</DELETED>
        <DELETED>    ``(2) $290,000,000 for each of fiscal years 2008 
        and 2009; and</DELETED>
        <DELETED>    ``(3) $300,000,000 for each of fiscal years 2010 
        and 2011.''.</DELETED>

<DELETED>SEC. 302. FUNDING FOR CERTAIN HIGH INTENSITY DRUG TRAFFICKING 
              AREAS.</DELETED>

<DELETED>    (a) Short Title.--This section may be cited as the 
``Dawson Family Community Protection Act''.</DELETED>
<DELETED>    (b) Findings.--Congress finds the following:</DELETED>
        <DELETED>    (1) In the early morning hours of October 16, 
        2002, the home of Carnell and Angela Dawson was firebombed in 
        apparent retaliation for Mrs. Dawson's notification to police 
        about persistent drug distribution activity in their East 
        Baltimore City neighborhood.</DELETED>
        <DELETED>    (2) The arson claimed the lives of Mr. and Mrs. 
        Dawson and their 5 young children, aged 9 to 14.</DELETED>
        <DELETED>    (3) The horrific murder of the Dawson family is a 
        stark example of domestic narco-terrorism.</DELETED>
        <DELETED>    (4) In all phases of counternarcotics law 
        enforcement--from prevention to investigation to prosecution to 
        reentry--the voluntary cooperation of ordinary citizens is a 
        critical component.</DELETED>
        <DELETED>    (5) Voluntary cooperation is difficult for law 
        enforcement officials to obtain when citizens feel that 
        cooperation carries the risk of violent retaliation by illegal 
        drug trafficking organizations and their affiliates.</DELETED>
        <DELETED>    (6) Public confidence that law enforcement is 
        doing all it can to make communities safe is a prerequisite for 
        voluntary cooperation among people who may be subject to 
        intimidation or reprisal (or both).</DELETED>
        <DELETED>    (7) Witness protection programs are insufficient 
        on their own to provide security because many individuals and 
        families who strive every day to make distressed neighborhoods 
        livable for their children, other relatives, and neighbors will 
        resist or refuse offers of relocation by local, State, and 
        Federal prosecutorial agencies and because, moreover, the 
        continued presence of strong individuals and families is 
        critical to preserving and strengthening the social fabric in 
        such communities.</DELETED>
        <DELETED>    (8) Where (as in certain sections of Baltimore 
        City) interstate trafficking of illegal drugs has severe 
        ancillary local consequences within areas designated as high 
        intensity drug trafficking areas, it is important that 
        supplementary High Intensity Drug Trafficking Areas Program 
        funds be committed to support initiatives aimed at making the 
        affected communities safe for the residents of those 
        communities and encouraging their cooperation with local, 
        State, and Federal law enforcement efforts to combat illegal 
        drug trafficking.</DELETED>
<DELETED>    (c) Funding for Certain High Intensity Drug Trafficking 
Areas.--Section 707, as amended by section 301, is amended by adding at 
the end the following:</DELETED>
<DELETED>    ``(q) Specific Purposes.--</DELETED>
        <DELETED>    ``(1) In general.--The Director shall ensure that, 
        of the amounts appropriated for a fiscal year for the Program, 
        at least $7,000,000 is used in high intensity drug trafficking 
        areas with severe neighborhood safety and illegal drug 
        distribution problems.</DELETED>
        <DELETED>    ``(2) Required uses.--The funds used under 
        paragraph (1) shall be used--</DELETED>
                <DELETED>    ``(A) to ensure the safety of 
                neighborhoods and the protection of communities, 
                including the prevention of the intimidation of 
                potential witnesses of illegal drug distribution and 
                related activities; and</DELETED>
                <DELETED>    ``(B) to combat illegal drug trafficking 
                through such methods as the Director considers 
                appropriate, such as establishing or operating (or 
                both) a toll-free telephone hotline for use by the 
                public to provide information about illegal drug-
                related activities.''.</DELETED>

<DELETED>SEC. 303. ASSESSMENT.</DELETED>

<DELETED>    The Director shall assess the ability of the HIDTA Program 
to respond to the so-called ``balloon effect'', whereby urban drug 
traffickers facing intensive law enforcement efforts expand and spread 
their trafficking and distribution into rural, suburban, and smaller 
urban areas by conducting a demonstration project examining the ability 
of the New York/New Jersey HIDTA, with its new single colocated 
Organized Crime and Drug Enforcement Task Force/High Intensity Drug 
Trafficking Area Strike Force and HIDTA Regional Intelligence Center, 
to address the movement of drug traffickers into the more rural, 
suburban, and smaller areas encompassed by the counties of Albany, 
Onondaga, Monroe, and Erie in New York State and by annexing these 
counties into the existing New York/New Jersey HIDTA.</DELETED>

                <DELETED>TITLE IV--TECHNOLOGY</DELETED>

<DELETED>SEC. 401. COUNTERDRUG TECHNOLOGY ASSESSMENT CENTER.</DELETED>

<DELETED>    (a) Chief Scientist.--Section 708(b) is amended to read as 
follows:</DELETED>
<DELETED>    ``(b) Chief Scientist.--There shall be at the head of the 
Center the Chief Scientist, who shall be appointed by the Director from 
among individuals qualified and distinguished in the area of science, 
medicine, engineering, or technology.''.</DELETED>
<DELETED>    (b) Responsibilities.--</DELETED>
        <DELETED>    (1) Research and development.--Section 708 is 
        amended by--</DELETED>
                <DELETED>    (A) redesignating subsection (d) as 
                subsection (e); and</DELETED>
                <DELETED>    (B) striking subsection (c) and inserting 
                the following:</DELETED>
<DELETED>    ``(c) Research and Development Responsibilities.--The 
Chief Scientist shall be responsible to the Director for--</DELETED>
        <DELETED>    ``(1) identifying and defining the short-, medium-
        , and long-term scientific and technological needs of Federal, 
        State, and local drug supply reduction agencies, including--
        </DELETED>
                <DELETED>    ``(A) advanced surveillance, tracking, and 
                radar imaging;</DELETED>
                <DELETED>    ``(B) electronic support 
                measures;</DELETED>
                <DELETED>    ``(C) communications;</DELETED>
                <DELETED>    ``(D) data fusion, advanced computer 
                systems, and artificial intelligence; and</DELETED>
                <DELETED>    ``(E) chemical, biological, radiological 
                (including neutron and electron), and other means of 
                detection;</DELETED>
        <DELETED>    ``(2) identifying demand reduction basic and 
        applied research needs and initiatives, in consultation with 
        affected National Drug Control Program agencies, including--
        </DELETED>
                <DELETED>    ``(A) improving treatment through 
                neuroscientific advances;</DELETED>
                <DELETED>    ``(B) improving the transfer of biomedical 
                research to the clinical setting; and</DELETED>
                <DELETED>    ``(C) in consultation with the National 
                Institute of Drug Abuse, and through interagency 
                agreements or grants, examining addiction and 
                rehabilitation research and the application of 
                technology to expanding the effectiveness and 
                availability of drug treatment;</DELETED>
        <DELETED>    ``(3) making a priority ranking of such needs 
        identified in paragraphs (1) and (2) according to fiscal and 
        technological feasibility, as part of a National Counterdrug 
        Research and Development Program;</DELETED>
        <DELETED>    ``(4) overseeing and coordinating counterdrug 
        technology initiatives with related activities of other Federal 
        civilian and military departments;</DELETED>
        <DELETED>    ``(5) providing support to the development and 
        implementation of the national drug control performance 
        measurement system established under subsection (c) of section 
        706; and</DELETED>
        <DELETED>    ``(6) transferring funds made available to a 
        National Drug Control Program Agency for counterdrug technology 
        research and development to another account within such agency 
        or to another National Drug Control Program Agency for 
        counterdrug technology research and development, pursuant to 
        the authority of the Director under section 704.</DELETED>
<DELETED>    ``(d) Limitation on Authority.--The authority granted to 
the Director under this section shall not extend to the awarding of 
contracts, management of individual projects, or other operational 
activities.''.</DELETED>
        <DELETED>    (2) Assistance and support.--Subsection (e) of 
        section 708, as redesignated by this section, is amended to 
        read as follows:</DELETED>
<DELETED>    ``(e) Assistance and Support to the Office of National 
Drug Control Policy.--The Secretary of Defense, the Secretary of 
Homeland Security, and the Secretary of Health and Human Services 
shall, to the maximum extent practicable, render assistance and support 
to the Office and to the Director in the conduct of counterdrug 
technology assessment.''.</DELETED>
        <DELETED>    (3) Technology transfer program.--Section 708 is 
        amended by adding at the end the following:</DELETED>
<DELETED>    ``(f) Technology Transfer Program.--</DELETED>
        <DELETED>    ``(1) Program.--The Chief Scientist, with the 
        advice and counsel of experts from State and local law 
        enforcement agencies, shall be responsible to the Director for 
        coordination and implementation of a counterdrug technology 
        transfer program.</DELETED>
        <DELETED>    ``(2) Purpose.--The purpose of the Technology 
        Transfer Program shall be for the Counterdrug Technology 
        Assessment Center to transfer technology and associated 
        training directly to State and local law enforcement 
        agencies.</DELETED>
        <DELETED>    ``(3) Priority of receipts.--Transfers shall be 
        made in priority order based on--</DELETED>
                <DELETED>    ``(A) the need of potential recipients for 
                such technology;</DELETED>
                <DELETED>    ``(B) the effectiveness of the technology 
                to enhance current counterdrug activities of potential 
                recipients; and</DELETED>
                <DELETED>    ``(C) the ability and willingness of 
                potential recipients to evaluate transferred 
                technology.</DELETED>
        <DELETED>    ``(4) Agreement authority.--The Director may enter 
        into an agreement with the Secretary of Homeland Security to 
        transfer technology with both counterdrug and homeland security 
        applications to State and local law enforcement agencies on a 
        reimbursable basis.</DELETED>
        <DELETED>    ``(5) Report.--On or before July 1 of each year, 
        the Director shall submit a report to the appropriate 
        congressional committees which addresses the 
        following:</DELETED>
                <DELETED>    ``(A) The number of requests received 
                during the previous 12 months.</DELETED>
                <DELETED>    ``(B) The number of requests fulfilled 
                during the previous 12 months.</DELETED>
                <DELETED>    ``(C) A summary of the criteria used in 
                making the determination on what requests were funded 
                and what requests were not funded.</DELETED>
                <DELETED>    ``(D) A general assessment of the future 
                needs of the program, based on expected changes in 
                threats, expected technologies, and likely need from 
                potential recipients.</DELETED>
                <DELETED>    ``(E) An assessment of the effectiveness 
                of the technologies transferred, based in part on the 
                evaluations provided by the recipients, with a 
                recommendation whether the technology should continue 
                to be offered through the program.''.</DELETED>

<DELETED>TITLE V--REAUTHORIZATION AND IMPROVEMENT OF THE NATIONAL ANTI-
                     DRUG MEDIA CAMPAIGN</DELETED>

<DELETED>SEC. 501. SHORT TITLE.</DELETED>

<DELETED>    This title may be cited as the ``National Youth Anti-Drug 
Media Campaign Reauthorization Act of 2006''.</DELETED>

<DELETED>SEC. 502. PURPOSES OF THE NATIONAL YOUTH ANTI-DRUG MEDIA 
              CAMPAIGN.</DELETED>

<DELETED>    The Drug-Free Media Campaign Act of 1998 (21 U.S.C. 1801 
et seq.) is amended--</DELETED>
        <DELETED>    (1) in section 101, by striking ``Drug-Free Media 
        Campaign Act of 1998'' and inserting ``National Youth Anti-Drug 
        Media Campaign Act''; and</DELETED>
        <DELETED>    (2) in section 102--</DELETED>
                <DELETED>    (A) in subsection (a), by striking 
                ``national media campaign'' and all that follows 
                through the period and inserting the following: 
                ``national youth anti-drug media campaign (referred to 
                in this subtitle as the `national media campaign') in 
                accordance with this subtitle for the purposes of--
                </DELETED>
        <DELETED>    ``(1) preventing drug abuse among young people in 
        the United States;</DELETED>
        <DELETED>    ``(2) increasing awareness of adults of the impact 
        of drug abuse on young people; and</DELETED>
        <DELETED>    ``(3) encouraging parents and other interested 
        adults to discuss with young people the dangers of illegal drug 
        use.''; and</DELETED>
                <DELETED>    (B) in subsection (b), by striking ``105'' 
                and inserting ``104''.</DELETED>

<DELETED>SEC. 503. ROLES AND RESPONSIBILITIES OF THE DIRECTOR, THE 
              PARTNERSHIP FOR A DRUG-FREE AMERICA, AND A MEDIA BUYING 
              CONTRACTOR.</DELETED>

<DELETED>    The Drug-Free Media Campaign Act of 1998 (21 U.S.C. 1801 
et seq.) is amended--</DELETED>
        <DELETED>    (1) by adding at the end the following:</DELETED>
<DELETED>    ``(c) Division of Responsibilities and Functions Under the 
Program.--</DELETED>
        <DELETED>    ``(1) In general.--The Director, in consultation 
        with the Partnership for a Drug-Free America, shall determine 
        the overall purposes and strategy of the national media 
        campaign.</DELETED>
        <DELETED>    ``(2) Responsibilities.--</DELETED>
                <DELETED>    ``(A) Director.--The Director shall be 
                responsible for implementing a focused national media 
                campaign to meet the purposes set forth in section 
                102(a), and shall approve--</DELETED>
                        <DELETED>    ``(i) the strategy of the national 
                        media campaign;</DELETED>
                        <DELETED>    ``(ii) all advertising and 
                        promotional material used in the national media 
                        campaign; and</DELETED>
                        <DELETED>    ``(iii) the plan for the purchase 
                        of advertising time and space for the national 
                        media campaign.</DELETED>
                <DELETED>    ``(B) The partnership for a drug-free 
                america.--The Director shall request that the 
                Partnership for a Drug-Free America--</DELETED>
                        <DELETED>    ``(i) develop and recommend 
                        strategies to achieve the goals of the national 
                        media campaign, including addressing national 
                        and local drug threats in specific regions or 
                        States, such as methamphetamine and 
                        ecstasy;</DELETED>
                        <DELETED>    ``(ii) create all advertising to 
                        be used in the national media campaign, except 
                        advertisements that are--</DELETED>
                                <DELETED>    ``(I) provided by other 
                                nonprofit entities pursuant to section 
                                103(c);</DELETED>
                                <DELETED>    ``(II) intended to reach a 
                                minority, ethnic, or other special 
                                audience that cannot be obtained at no 
                                cost (not including production costs 
                                and talent reuse payments), provided 
                                that any such advertising material is 
                                reviewed by the Partnership for a Drug-
                                Free America; or</DELETED>
                                <DELETED>    ``(III) any other 
                                advertisements that the Partnership for 
                                a Drug-Free America determines it is 
                                unable to provide.</DELETED>
                <DELETED>    ``(C) Media buying contractor.--The 
                Director shall enter into a contract with a media 
                buying contractor to plan and purchase advertising time 
                and space for the national media campaign. The media 
                buying contractor shall not provide any service or 
                material, or conduct any function or activity which can 
                be provided by the Partnership for a Drug-Free America, 
                as defined in section 403(2)(B)''; and</DELETED>
        <DELETED>    (2) in section 103--</DELETED>
                <DELETED>    (A) in subparagraph (A), by inserting ``, 
                including the strategic planning for, and accounting 
                of, such purchases'' after ``space'';</DELETED>
                <DELETED>    (B) in subparagraph (C), by striking 
                ``out-of-pocket''; and</DELETED>
                <DELETED>    (C) in subparagraph (F), by striking ``the 
                Office of National Drug Control Policy'' and inserting 
                ``either the Office of National Drug Control Policy or 
                the designee of the Office''.</DELETED>

<DELETED>SEC. 504. RESPONSIBLE USE OF FEDERAL FUNDS FOR THE NATIONAL 
              YOUTH ANTI-DRUG MEDIA CAMPAIGN.</DELETED>

<DELETED>    The Drug-Free Media Campaign Act of 1998 (21 U.S.C. 1801 
et seq.) is amended--</DELETED>
        <DELETED>    (1) in section 103, by striking paragraph (2) and 
        inserting the following:</DELETED>
        <DELETED>    ``(2) Advertising.--</DELETED>
                <DELETED>    ``(A) In general.--Except as provided in 
                subparagraph (B), in carrying out this subtitle, the 
                Director shall ensure that sufficient funds are 
                allocated to meet the stated goals of the national 
                media campaign.</DELETED>
                <DELETED>    ``(B) Exception.--No funds shall be used 
                for the creative development of advertisements (not 
                including out-of-pocket production costs and talent 
                reuse payments) except when--</DELETED>
                        <DELETED>    ``(i) the advertisements are 
                        intended to reach a minority, ethnic, or other 
                        special audience that cannot be obtained at no 
                        cost (not including production costs and talent 
                        reuse payments); or</DELETED>
                        <DELETED>    ``(ii) the Partnership for a Drug-
                        Free America, determines that it is unable to 
                        provide such advertisements.'';</DELETED>
        <DELETED>    (2) in subsection (b), by striking ``105'' and 
        inserting ``104'';</DELETED>
        <DELETED>    (3) by striking subsection (c) and inserting the 
        following:</DELETED>
<DELETED>    ``(c) Matching Requirement.--</DELETED>
        <DELETED>    ``(1) No cost match.--</DELETED>
                <DELETED>    ``(A) In general.--Except as provided in 
                subparagraph (B), amounts made available for the 
                national media campaign under section 106 shall be used 
                to require a no cost match of equivalent value of 
                advertising broadcast time, print space, or in-kind 
                contributions to the national media campaign.</DELETED>
                <DELETED>    ``(B) Exception.--The Director shall 
                ensure that all no cost matches of advertising 
                material, time, space, or in-kind contributions 
                provided pursuant to subparagraph (A) directly relate 
                to substance abuse prevention and specifically promote 
                1 or more of the specific purposes set forth in section 
                102(a). This may include antismoking messages that are 
                produced by nonprofit organizations and are targeted 
                toward minors.</DELETED>
        <DELETED>    ``(2) Sponsorship identification.--Any advertising 
        material donated to the national media campaign at no cost 
        shall not be subject to the sponsorship identification 
        provisions in section 317 of the Communications Act of 1934 (47 
        U.S.C. 317).'';</DELETED>
        <DELETED>    (4) by adding at the end the following:</DELETED>
<DELETED>    ``(d) Responsible Use of Federal Funds.--</DELETED>
        <DELETED>    ``(1) In general.--The Director shall ensure 
        that--</DELETED>
                <DELETED>    ``(A) for each fiscal year, not less than 
                77 percent of the amounts appropriated under this 
                subtitle shall be used for the activities allowed under 
                section 103(a)(1)(A);</DELETED>
                <DELETED>    ``(B) no Federal funds provided under this 
                subtitle are used to pay any entity for any activity or 
                service that duplicates, in whole or in part, any 
                material, function, activity, or service provided by 
                the Partnership for a Drug-Free America, as defined in 
                section 403(2)(B); and</DELETED>
                <DELETED>    ``(C) no more than $5,000,000 is used in 
                each fiscal year to develop advertising material 
                pursuant to subsection (a)(2)(B)(ii).''.</DELETED>

<DELETED>SEC. 505. AUTHORIZATION FOR NATIONAL YOUTH ANTI-DRUG MEDIA 
              CAMPAIGN.</DELETED>

<DELETED>    The Drug-Free Media Campaign Act of 1998 (21 U.S.C. 1801 
et seq.) is amended by striking sections 104 and 105 and inserting the 
following:</DELETED>

<DELETED>``SEC. 104. AUTHORIZATION OF APPROPRIATIONS.</DELETED>

<DELETED>    ``There is authorized to be appropriated to the Office of 
National Drug Control Policy to carry out this subtitle, $195,000,000 
for each of the fiscal years 2006 through 2010.''.</DELETED>

    <DELETED>TITLE VI--AUTHORIZATIONS AND EXTENSION OF TERMINATION 
                             DATE</DELETED>

<DELETED>SEC. 601. AUTHORIZATION OF APPROPRIATIONS.</DELETED>

<DELETED>    Section 714 is amended--</DELETED>
        <DELETED>    (1) by striking ``title,'' and inserting ``title 
        except activities otherwise specified,''; and</DELETED>
        <DELETED>    (2) by striking ``1999 through 2003'' and 
        inserting ``2006 through 2010''.</DELETED>

<DELETED>SEC. 602. EXTENSION OF TERMINATION DATE.</DELETED>

<DELETED>    Section 715(a) is amended by striking ``September 30, 
2003, this title and the amendments made by this title'' and inserting 
``September 30, 2008, this title and the amendments made to this 
title''.</DELETED>

            <DELETED>TITLE VII--ANTI-DOPING AGENCY</DELETED>

<DELETED>SEC. 701. DESIGNATION OF UNITED STATES ANTI-DOPING 
              AGENCY.</DELETED>

<DELETED>    (a) Definitions.--In this title:</DELETED>
        <DELETED>    (1) United states olympic committee.--The term 
        ``United States Olympic Committee'' means the organization 
        established by the ``Ted Stevens Olympic and Amateur Sports 
        Act'' (36 U.S.C. 220501 et seq.).</DELETED>
        <DELETED>    (2) Amateur athletic competition.--The term 
        ``amateur athletic competition'' means a contest, game, meet, 
        match, tournament, regatta, or other event in which amateur 
        athletes compete (36 U.S.C. 220501(b)(2)).</DELETED>
        <DELETED>    (3) Amateur athlete.--The term ``amateur athlete'' 
        means an athlete who meets the eligibility standards 
        established by the national governing body or paralympic sports 
        organization for the sport in which the athlete competes (36 
        U.S.C. 22501(b)(1)).</DELETED>
<DELETED>    (b) In General.--The United States Anti-Doping Agency 
shall--</DELETED>
        <DELETED>    (1) serve as the independent anti-doping 
        organization for the amateur athletic competitions recognized 
        by the United States Olympic Committee;</DELETED>
        <DELETED>    (2) ensure that athletes participating in amateur 
        athletic activities recognized by the United States Olympic 
        Committee are prevented from using performance-enhancing 
        drugs;</DELETED>
        <DELETED>    (3) implement anti-doping education, research, 
        testing, and adjudication programs to prevent United States 
        Amateur Athletes participating in any activity recognized by 
        the United States Olympic Committee from using performance-
        enhancing drugs; and</DELETED>
        <DELETED>    (4) serve as the United States representative 
        responsible for coordination with other anti-doping 
        organizations coordinating amateur athletic competitions 
        recognized by the United States Olympic Committee to ensure the 
        integrity of athletic competition, the health of the athletes 
        and the prevention of use of performance-enhancing drugs by 
        United States amateur athletes.</DELETED>

<DELETED>SEC. 702. RECORDS, AUDIT, AND REPORT.</DELETED>

<DELETED>    (a) Records.--The United States Anti-Doping Agency shall 
keep correct and complete records of account.</DELETED>
<DELETED>    (b) Report.--The United States Anti-Doping Agency shall 
submit an annual report to Congress which shall include--</DELETED>
        <DELETED>    (1) an audit conducted and submitted in accordance 
        with section 10101 of title 36, United States Code; 
        and</DELETED>
        <DELETED>    (2) a description of the activities of the 
        agency.</DELETED>

<DELETED>SEC. 703. AUTHORIZATION OF APPROPRIATIONS.</DELETED>

<DELETED>    There are authorized to be appropriated to the United 
States Anti-Doping Agency--</DELETED>
        <DELETED>    (1) for fiscal year 2007, $9,700,000;</DELETED>
        <DELETED>    (2) for fiscal year 2008, $10,300,000;</DELETED>
        <DELETED>    (3) for fiscal year 2009, $10,600,000;</DELETED>
        <DELETED>    (4) for fiscal year 2010, $11,000,000; 
        and</DELETED>
        <DELETED>    (5) for fiscal year 2011, $11,500,000.</DELETED>

          <DELETED>TITLE VIII--DRUG-FREE COMMUNITIES</DELETED>

<DELETED>SEC. 801. REAUTHORIZATION.</DELETED>

<DELETED>    Section 1024(a) of the Drug-Free Communities Act of 1997 
(21 U.S.C. 1524(a)) is amended--</DELETED>
        <DELETED>    (1) in paragraph (9), by striking ``and'' after 
        the semicolon;</DELETED>
        <DELETED>    (2) in paragraph (10), by striking the period and 
        inserting a semicolon; and</DELETED>
        <DELETED>    (3) by adding at the end the following:</DELETED>
        <DELETED>    ``(11) $109,000,000 for fiscal year 
        2008;</DELETED>
        <DELETED>    ``(12) $119,000,000 for fiscal year 
        2009;</DELETED>
        <DELETED>    ``(13) $129,000,000 for fiscal year 
        2010;</DELETED>
        <DELETED>    ``(14) $139,000,000 for fiscal year 2011; 
        and</DELETED>
        <DELETED>    ``(15) $149,000,000 for fiscal year 
        2012.''.</DELETED>

<DELETED>SEC. 802. SUSPENSION OF GRANTS.</DELETED>

<DELETED>    (a) In General.--Section 1032(b) of the Drug-Free 
Communities Act of 1997 (21 U.S.C. 1532(b)) is amended by adding at the 
end the following:</DELETED>
        <DELETED>    ``(4) Process for suspension.--A grantee shall not 
        be suspended or terminated under paragraph (1)(A)(ii), 
        (2)(A)(iii), or (3)(E) unless that grantee is afforded a fair, 
        timely, and independent appeal prior to such suspension or 
        termination.''.</DELETED>
<DELETED>    (b) Report to Congress.--Not later than 60 days after the 
date of enactment of this Act, the Director of the Office of National 
Drug Control Policy shall submit to Congress a report detailing the 
appeals process required by section 1032 (b)(4) of the Drug-Free 
Communities Act of 1997, as added by subsection (a).</DELETED>

<DELETED>SEC. 803. GRANT AWARD INCREASE.</DELETED>

<DELETED>    Subsections (b)(1)(A)(iv), (b)(2)(C)(i), and (b)(3)(F) of 
section 1032 of the Drug-Free Communities Act of 1997 (21 U.S.C. 1532) 
are amended by striking ``$100,000'' and inserting 
``$125,000''.</DELETED>

<DELETED>SEC. 804. PROHIBITION ON ADDITIONAL ELIGIBILITY 
              CRITERIA.</DELETED>

<DELETED>    Section 1032(a) of the Drug-Free Communities Act of 1997 
(21 U.S.C. 1532(a)) is amended by adding at the end the 
following:</DELETED>
        <DELETED>    ``(7) Additional criteria.--The Director shall not 
        impose any eligibility criteria on new applicants or renewal 
        grantees not provided in this chapter.''.</DELETED>

<DELETED>SEC. 805. SUPPLEMENTAL GRANTS FOR COALITIONS.</DELETED>

<DELETED>    The Drug-Free Communities Act of 1997 (21 U.S.C. 1521 et 
seq.) is amended by inserting after section 1035 the 
following:</DELETED>

<DELETED>``SEC. 1036. SUPPLEMENTAL GRANTS FOR COALITIONS WITH A MAJOR 
              LOCAL DRUG CRISIS.</DELETED>

<DELETED>    ``(a) Authority to Make Grants.--As part of the program 
established under section 1031, the Director may award an initial grant 
under this subsection, and renewal grants under subsection (f), to any 
coalition awarded a grant under section 1032 that meets the criteria 
specified in subsection (d) in order to fund a coalition dealing with a 
major local drug crisis.</DELETED>
<DELETED>    ``(b) Treatment With Other Grants.--</DELETED>
        <DELETED>    ``(1) Supplement.--A grant awarded to a coalition 
        under this section is in addition to any grant awarded to the 
        coalition under section 1032.</DELETED>
        <DELETED>    ``(2) Requirement for basic grant.--A coalition 
        may not be awarded a grant under this section for a fiscal year 
        unless the coalition was awarded a grant or renewal grant under 
        section 1032(b) for that fiscal year.</DELETED>
<DELETED>    ``(c) Application.--A coalition seeking a grant under this 
section shall submit to the Administrator an application for the grant 
in such form and manner as the Administrator may require.</DELETED>
<DELETED>    ``(d) Criteria.--A coalition meets the criteria specified 
in this subsection if the coalition--</DELETED>
        <DELETED>    ``(1) has achieved by or through it's own efforts 
        measurable results in the prevention and reduction of substance 
        use among youth generally;</DELETED>
        <DELETED>    ``(2) has documented a highly, statistically 
        significant increase in a specific drug, from a baseline 
        determined by locally collected data, that can be defined as a 
        local drug crisis; and</DELETED>
        <DELETED>    ``(3) submits to the Administrator a detailed plan 
        for addressing the specific local drug crisis.</DELETED>
<DELETED>    ``(e) Use of Grant Funds.--A coalition awarded a grant 
under this section shall use the grant amount for implementing 
comprehensive, community-wide strategies that address their local drug 
crises in accordance with the detailed plan submitted to the 
Administrator under subsection (d)(3).</DELETED>
<DELETED>    ``(f) Renewal Grants.--The Administrator may make a 
renewal grant to any coalition awarded a grant under subsection (a), or 
a previous renewal grant under this subsection, if the coalition at the 
time of the application for such renewal grant--</DELETED>
        <DELETED>    ``(1) continues to meet the criteria specified in 
        subsection (d); and</DELETED>
        <DELETED>    ``(2) has made demonstrable progress in addressing 
        the specific local drug crisis.</DELETED>
<DELETED>    ``(g) Grant Amounts.--</DELETED>
        <DELETED>    ``(1) In general.--Subject to paragraphs (2) and 
        (3) the total amount of grants awarded to a coalition under 
        this section for a fiscal year may not exceed the amount of 
        non-Federal funds raised by the coalition, including in kind 
        contributions, for that fiscal year.</DELETED>
        <DELETED>    ``(2) Initial grants.--The amount of the initial 
        grant awarded to a coalition under subsection (a) may not 
        exceed $50,000.</DELETED>
        <DELETED>    ``(3) Renewal grants.--The total amount of renewal 
        grants awarded to a coalition under subsection (f) for any 
        fiscal year may not exceed $50,000.</DELETED>
<DELETED>    ``(h) Fiscal Year Limitation on the Amount Available for 
Grants.--The total amount available for grants under this section, 
including renewal grants under subsection (f), in any fiscal year may 
not exceed the amount equal to 5 percent of the actual amount 
appropriated for that fiscal year.''.</DELETED>

<DELETED>SEC. 806. NATIONAL COMMUNITY ANTIDRUG COALITION 
              INSTITUTE.</DELETED>

<DELETED>    Section 4 of Public Law 107-82 (21 U.S.C. 1521 note), 
reauthorizing the Drug-Free Communities Support Program, is amended--
</DELETED>
        <DELETED>    (1) by amending subsection (a) to read as 
        follows:</DELETED>
<DELETED>    ``(a) In General.--The Director of the Office of National 
Drug Control Policy shall, using amounts authorized to be appropriated 
by subsection (d), make a directed grant to Community Anti-Drug 
Coalitions of America to provide for the continuation of the National 
Community Antidrug Coalition Institute.'';</DELETED>
        <DELETED>    (2) by striking subsection (b) and redesignating 
        subsections (c) and (d) as (b) and (c), respectively; 
        and</DELETED>
        <DELETED>    (3) in subsection (c), as redesignated by 
        paragraph (2), by adding at the end the following:</DELETED>
        <DELETED>    ``(4) For each of the fiscal years 2008 through 
        2012, $2,000,000.''.</DELETED>

<DELETED>SEC. 807. CONTRACTING REQUIREMENT.</DELETED>

<DELETED>    Section 1031(d) of the Drug-Free Communities Act of 1997 
(21 U.S.C. 1531(d)) is amended by adding at the end the following: 
``The Director shall delegate all authority for grant eligibility 
determinations, review, selection, management, and appeals to another 
qualified national drug control agency.''.</DELETED>

    <DELETED>TITLE IX--NATIONAL GUARD COUNTERDRUG SCHOOLS</DELETED>

<DELETED>SEC. 901. NATIONAL GUARD COUNTERDRUG SCHOOLS.</DELETED>

<DELETED>    (a) Authority To Operate.--Under such regulations as the 
Secretary of Defense may prescribe, the Chief of the National Guard 
Bureau may establish and operate, or provide financial assistance to 
the States to establish and operate, not more than five schools (to be 
known generally as ``National Guard counterdrug schools'').</DELETED>
<DELETED>    (b) Purpose.--The purpose of the National Guard 
counterdrug schools shall be the provision by the National Guard of 
training in drug interdiction and counterdrug activities and drug 
demand reduction activities to personnel of the following:</DELETED>
        <DELETED>    (1) Federal agencies.</DELETED>
        <DELETED>    (2) State and local law enforcement 
        agencies.</DELETED>
        <DELETED>    (3) Community-based organizations engaged in such 
        activities.</DELETED>
        <DELETED>    (4) Other non-Federal governmental and private 
        entities and organizations engaged in such 
        activities.</DELETED>
<DELETED>    (c) Counterdrug Schools Specified.--The National Guard 
counterdrug schools operated under the authority in subsection (a) are 
as follows:</DELETED>
        <DELETED>    (1) The National Interagency Civil-Military 
        Institute (NICI), San Luis Obispo, California.</DELETED>
        <DELETED>    (2) The Multi-Jurisdictional Counterdrug Task 
        Force Training (MCTFT), St. Petersburg, Florida.</DELETED>
        <DELETED>    (3) The Midwest Counterdrug Training Center 
        (MCTC), Johnston, Iowa.</DELETED>
        <DELETED>    (4) The Regional Counterdrug Training Academy 
        (RCTA), Meridian, Mississippi.</DELETED>
        <DELETED>    (5) The Northeast Regional Counterdrug Training 
        Center (NCTC), Fort Indiantown Gap, Pennsylvania.</DELETED>
<DELETED>    (d) Use of National Guard Personnel.--</DELETED>
        <DELETED>    (1) In general.--To the extent provided for in the 
        State drug interdiction and counterdrug activities plan of a 
        State in which a National Guard counterdrug school is located, 
        personnel of the National Guard of that State who are ordered 
        to perform full-time National Guard duty authorized under 
        section 112(b) of that title 32, United States Code, may 
        provide training referred to in subsection (b) at that 
        school.</DELETED>
        <DELETED>    (2) Definition.--In this subsection, the term 
        ``State drug interdiction and counterdrug activities plan'', in 
        the case of a State, means the current plan submitted by the 
        Governor of the State to the Secretary of Defense under section 
        112 of title 32, United States Code.</DELETED>
<DELETED>    (e) Treatment Under Authority To Provide Counterdrug 
Support.--The provisions of section 1004 of the National Defense 
Authorization Act for Fiscal Year 1991 (Public Law 101-510; 10 U.S.C. 
374 note) shall apply to any activities of a National Guard counterdrug 
school under this section that are for an agency referred to in 
subsection (a) of such section 1004 and for a purpose set forth in 
subsection (b) of such section 1004.</DELETED>
<DELETED>    (f) Annual Reports on Activities.--</DELETED>
        <DELETED>    (1) In general.--Not later than February 1 each 
        year, the Secretary of Defense shall submit to Congress a 
        report on the activities of the National Guard counterdrug 
        schools during the preceding year.</DELETED>
        <DELETED>    (2) Contents.--Each report under paragraph (1) 
        shall set forth the following:</DELETED>
                <DELETED>    (A) Funding.--The amount made available 
                for each National Guard counterdrug school during the 
                fiscal year ending in the year preceding the year in 
                which such report is submitted.</DELETED>
                <DELETED>    (B) Activities.--A description of the 
                activities of each National Guard counterdrug school 
                during the year preceding the year in which such report 
                is submitted.</DELETED>
<DELETED>    (g) Authorization of Appropriations.--</DELETED>
        <DELETED>    (1) In general.--There is hereby authorized to be 
        appropriated for the Department of Defense for the National 
        Guard for each of fiscal years 2006 through 2010, $30,000,000 
        for purposes of the National Guard counterdrug schools in such 
        fiscal year.</DELETED>
        <DELETED>    (2) Construction.--The amount authorized to be 
        appropriated by paragraph (1) for a fiscal year is in addition 
        to any other amount authorized to be appropriated for the 
        Department of Defense for the National Guard for such fiscal 
        year.</DELETED>

          <DELETED>TITLE X--MISCELLANEOUS PROVISIONS</DELETED>

<DELETED>SEC. 1001. REPEALS.</DELETED>

<DELETED>    (a) Act.--Sections 709, 710, and 711 are 
repealed.</DELETED>
<DELETED>    (b) Forfeiture Assets.--Section 6073 of the Assets 
Forfeiture Amendments Act of 1988 (21 U.S.C. 1509) is 
repealed.</DELETED>

<DELETED>SEC. 1002. CONTROLLED SUBSTANCES ACT AMENDMENTS.</DELETED>

<DELETED>    Section 303(g)(2)(B)(iii) of the Controlled Substances Act 
(21 U.S.C. 823(g)(2)(B)(iii)) is amended by striking ``except that the 
Secretary'' and inserting the following: ``unless, not sooner than 1 
year after the date on which the practitioner submitted the initial 
notification, the practitioner submits a second notification to the 
Secretary of the need and intent of the practitioner to treat more than 
such applicable number of patients. A second notification under this 
clause shall contain the certifications required by clauses (i) and 
(ii) of this subparagraph. The Secretary''.</DELETED>

<DELETED>SEC. 1003. REPORT ON INTELLIGENCE SHARING.</DELETED>

<DELETED>    Not later than 180 days after the date of enactment of 
this Act, the Director shall submit to Congress a report--</DELETED>
        <DELETED>    (1) evaluating existing and planned intelligence 
        systems used by Federal, State, and local law enforcement 
        agencies responsible for drug trafficking and drug production 
        enforcement; and</DELETED>
        <DELETED>    (2) addressing--</DELETED>
                <DELETED>    (A) the current intelligence systems used 
                by Federal, State, and local law enforcement 
                agencies;</DELETED>
                <DELETED>    (B) the compatibility of such systems in 
                ensuring access and availability of intelligence to 
                Federal, State, and local law enforcement;</DELETED>
                <DELETED>    (C) the extent to which Federal, State, 
                and local law enforcement are sharing intelligence 
                information to assess current threats and design 
                appropriate enforcement strategies; and</DELETED>
                <DELETED>    (D) the measures needed to ensure and to 
                promote effective information sharing among 
                intelligence systems operated by Federal, State, and 
                local law enforcement agencies responsible for drug 
                trafficking and drug production enforcement.</DELETED>

<DELETED>SEC. 1004. REQUIREMENT FOR SOUTH AMERICAN HEROIN 
              STRATEGY.</DELETED>

<DELETED>    (a) In General.--Not later than 90 days after the date of 
enactment of this Act, the Director shall submit to Congress a 
comprehensive strategy that addresses the increased threat from South 
American heroin, and in particular Colombian heroin, and the emerging 
threat from opium poppy grown in Peru and often intended for transit to 
Columbia for processing into heroin.</DELETED>
<DELETED>    (b) Contents.--The strategy submitted under subsection (a) 
shall include--</DELETED>
        <DELETED>    (1) opium eradication efforts to eliminate the 
        problem at the source to prevent heroin from entering the 
        stream of commerce;</DELETED>
        <DELETED>    (2) interdiction and precursor chemical 
        controls;</DELETED>
        <DELETED>    (3) demand reduction and treatment;</DELETED>
        <DELETED>    (4) alternative development programs, including 
        direct assistance to regional governments to demobilize and 
        provide alternative livelihoods to former members of insurgent 
        or other groups engaged in heroin, cocoa, or other illicit drug 
        production or trafficking;</DELETED>
        <DELETED>    (5) efforts to inform and involve local citizens 
        in the programs described in paragraphs (1) through (4), such 
        as through leaflets advertising rewards for 
        information;</DELETED>
        <DELETED>    (6) provisions that ensure the maintenance at 
        current levels of efforts to eradicate coca in Colombia; 
        and</DELETED>
        <DELETED>    (7) an assessment of the specific level of funding 
        and resources necessary to simultaneously address the threat 
        from South American heroin and the threat from Colombian and 
        Peruvian coca.</DELETED>
<DELETED>    (c) Treatment of Classified or Law Enforcement Sensitive 
Information.--Any content of the strategy submitted under subsection 
(a) that involves information classified under criteria established by 
an Executive order, or whose public disclosure, as determined by the 
Director or the head of any relevant Federal agency, would be 
detrimental to the law enforcement of national security activities of 
any Federal, foreign, or international agency, shall be presented to 
Congress separately from the rest of the strategy.</DELETED>

<DELETED>SEC. 1005. MODEL ACTS.</DELETED>

<DELETED>    (a) In General.--The Director shall enter into an 
agreement with a nonprofit corporation that works with States on laws 
and policies to address alcohol and other drug issues, under which the 
corporation shall revise the model State drug laws developed by the 
President's Commission on Model State Drug Laws and draft supplementary 
model acts to meet changes in States' substance abuse issues.</DELETED>
<DELETED>    (b) Authorization of Appropriations.--There are authorized 
to be appropriated $1,500,000 to carry out this section.</DELETED>

SECTION 1. SHORT TITLE, REFERENCE, AND TABLE OF CONTENTS.

    (a) Short Title.--This Act may be cited as the ``Office of National 
Drug Control Policy Reauthorization Act of 2006''.
    (b) Amendment of Office of National Drug Control Policy 
Reauthorization Act of 1998.--Except as otherwise expressly provided, 
whenever in this Act an amendment or repeal is expressed in terms of an 
amendment to, or repeal of, a section or other provision, the reference 
shall be considered to be made to a section or other provision of the 
Office of National Drug Control Policy Reauthorization Act of 1998 
(Public Law 105-277; 21 U.S.C. 1701 et seq.).
    (c) Table of Contents.--The table of contents for this Act is as 
follows:

Sec. 1. Short title, reference, and table of contents.

  TITLE I--ORGANIZATION OF OFFICE OF NATIONAL DRUG CONTROL POLICY AND 
                       ROLES AND RESPONSIBILITIES

Sec. 101. Amendments to definitions.
Sec. 102. Establishment of the Office of National Drug Control Policy.
Sec. 103. Appointment and responsibilities of the Director.
Sec. 104. Amendments to ensure coordination with other agencies.
Sec. 105. Budgetary matters.

              TITLE II--THE NATIONAL DRUG CONTROL STRATEGY

Sec. 201. Annual preparation and submission of National Drug Control 
                            Strategy.
Sec. 202. Performance measurements.
Sec. 203. Annual report requirement.

            TITLE III--HIGH INTENSITY DRUG TRAFFICKING AREAS

Sec. 301. High Intensity Drug Trafficking Areas Program.
Sec. 302. Funding for certain high intensity drug trafficking areas.
Sec. 303. Assessment.

                          TITLE IV--TECHNOLOGY

Sec. 401. Counterdrug Technology Assessment Center.

  TITLE V--REAUTHORIZATION AND IMPROVEMENT OF THE NATIONAL ANTI-DRUG 
                             MEDIA CAMPAIGN

Sec. 501. Short title.
Sec. 502. Purposes of the National Youth Anti-Drug Media Campaign.
Sec. 503. Roles and responsibilities of the Director, the Partnership 
                            for a Drug-Free America, and a media buying 
                            contractor.
Sec. 504. Responsible use of Federal funds for the National Youth Anti-
                            Drug Media Campaign.
Sec. 505. Authorization for National Youth Anti-Drug Media Campaign.

       TITLE VI--AUTHORIZATIONS AND EXTENSION OF TERMINATION DATE

Sec. 601. Authorization of appropriations.
Sec. 602. Extension of termination date.

                     TITLE VII--ANTI-DOPING AGENCY

Sec. 701. Designation of United States Anti-Doping Agency.
Sec. 702. Records, audit, and report.
Sec. 703. Authorization of appropriations.

                   TITLE VIII--DRUG-FREE COMMUNITIES

Sec. 801. Reauthorization.
Sec. 802. Suspension of grants.
Sec. 803. Grant award increase.
Sec. 804. Prohibition on additional eligibility criteria.
Sec. 805. Supplemental grants for coalitions.
Sec. 806. National Community Anti-Drug Coalition Institute.
Sec. 807. Contracting requirement.

              TITLE IX--NATIONAL GUARD COUNTERDRUG SCHOOLS

Sec. 901. National Guard counterdrug schools.

TITLE X--NATIONAL METHAMPHETAMINE INFORMATION CLEARINGHOUSE ACT OF 2006

Sec. 1001. Short title.
Sec. 1002. Definitions.
Sec. 1003. Establishment of clearinghouse and advisory council.
Sec. 1004. NMIC requirements and review.
Sec. 1005. Authorization of appropriations.

                   TITLE XI--MISCELLANEOUS PROVISIONS

Sec. 1101. Repeals.
Sec. 1102. Controlled Substances Act amendments.
Sec. 1103. Report on intelligence sharing.
Sec. 1104. Requirement for South American heroin strategy.
Sec. 1105. Model acts.
Sec. 1106. Study on iatrogenic addiction associated with prescription 
                            opioid analgesic drugs.
Sec. 1107. Requirement for strategy to stop Internet advertising of 
                            prescription medicines without a 
                            prescription.
Sec. 1108. Requirement for study on diversion and inappropriate uses of 
                            prescription drugs.

  TITLE I--ORGANIZATION OF OFFICE OF NATIONAL DRUG CONTROL POLICY AND 
                       ROLES AND RESPONSIBILITIES

SEC. 101. AMENDMENTS TO DEFINITIONS.

    (a) Demand Reduction.--Section 702(1) is amended--
            (1) in subparagraph (F), by striking ``and'' after the 
        semicolon; and
            (2) in subparagraph (G), by striking the period and 
        inserting ``; and''; and
            (3) by adding at the end the following:
                    ``(H) international drug abuse education, 
                prevention, treatment, research, rehabilitation 
                activities, and interventions for drug abuse and 
                dependence.''.
    (b) National Drug Control Program.--Section 702(6) is amended by 
adding before the period the following: ``, including any activities 
involving supply reduction, demand reduction, or State and local 
affairs''.
    (c) Office.--Section 702(9) is amended by striking ``implicates'' 
and inserting ``indicates''.
    (d) State and Local Affairs.--Paragraph (10) of section 702 is 
amended to read as follows:
            ``(10) State and local affairs.--The term `State and local 
        affairs' means domestic activities conducted by a National Drug 
        Control Program agency that are intended to reduce the 
        availability and use of illegal drugs, including--
                    ``(A) coordination and enhancement of Federal, 
                State, and local law enforcement drug control efforts;
                    ``(B) coordination and enhancement of efforts among 
                National Drug Control Program agencies and State and 
                local demand reduction and supply reduction agencies;
                    ``(C) coordination and enhancement of Federal, 
                State, and local law enforcement initiatives to gather, 
                analyze, and disseminate information and intelligence 
                relating to drug control among domestic law enforcement 
                agencies; and
                    ``(D) other coordinated and joint initiatives among 
                Federal, State, and local agencies to promote 
                comprehensive drug control strategies designed to 
                reduce the demand for, and the availability of, illegal 
                drugs.''.
    (e) Supply Reduction.--Section 702(11) is amended to read as 
follows:
            ``(11) Supply reduction.--The term `supply reduction' means 
        any activity or program conducted by a National Drug Control 
        Program agency that is intended to reduce the availability or 
        use of illegal drugs in the United States or abroad, 
        including--
                    ``(A) law enforcement outside the United States;
                    ``(B) source country programs, including economic 
                development programs primarily intended to reduce the 
                production or trafficking of illicit drugs;
                    ``(C) activities to control international 
                trafficking in, and availability of, illegal drugs, 
                including--
                            ``(i) accurate assessment and monitoring of 
                        international drug production and interdiction 
                        programs and policies; and
                            ``(ii) coordination and promotion of 
                        compliance with international treaties relating 
                        to the production, transportation, or 
                        interdiction of illegal drugs;
                    ``(D) activities to conduct and promote 
                international law enforcement programs and policies to 
                reduce the supply of drugs; and
                    ``(E) activities to facilitate and enhance the 
                sharing of domestic and foreign intelligence 
                information among National Drug Control Program 
                agencies, relating to the production and trafficking of 
                drugs in the United States and in foreign countries.''.
    (f) Definitions of Appropriate Congressional Committees and Law 
Enforcement.--Section 702 is amended by adding at the end the 
following:
            ``(12) Appropriate congressional committees.--Except where 
        otherwise provided, the term `appropriate congressional 
        committees' means the Committee on the Judiciary, the Committee 
        on Appropriations, and the Caucus on International Narcotics 
        Control of the Senate and the Committee on Government Reform, 
        the Committee on the Judiciary, and the Committee on 
        Appropriations of the House of Representatives.
            ``(13) Law enforcement.--The term `law enforcement' or 
        `drug law enforcement' means all efforts by a Federal, State, 
        or local government agency to enforce the drug laws of the 
        United States or any State, including investigation, arrest, 
        prosecution, and incarceration or other punishments or 
        penalities.''.

SEC. 102. ESTABLISHMENT OF THE OFFICE OF NATIONAL DRUG CONTROL POLICY.

    (a) Responsibilities.--Section 703(a) is amended to read as 
follows:
    ``(a) Establishment of Office.--There is established in the 
Executive Office of the President an Office of National Drug Control 
Policy, which shall--
            ``(1) develop national drug control policy;
            ``(2) coordinate and oversee the implementation of the 
        national drug control policy;
            ``(3) assess and certify the adequacy of National Drug 
        Control Programs and the budget for those programs;
            ``(4) evaluate the effectiveness of National Drug Control 
        Program agencies' programs; and
            ``(5) develop specific goals and performance measurements 
        needed to assess the effectiveness of--
                    ``(A) the national drug control policy; and
                    ``(B) the programs of the National Drug Control 
                Program agencies.''.
    (b) Positions.--Section 703(b) is amended to read as follows:
    ``(b) Director of National Drug Control Policy and Deputy 
Directors.--
            ``(1) Director.--There shall be a Director of National Drug 
        Control Policy who shall head the Office (referred to in this 
        Act as the `Director').
            ``(2) Deputy director.--There shall be a Deputy Director of 
        National Drug Control Policy who shall report directly to the 
        Director (referred to in this Act as the `Deputy Director').
            ``(3) Other deputy directors.--
                    ``(A) In general.--There shall be a Deputy Director 
                for Demand Reduction, a Deputy Director for Supply 
                Reduction, and a Deputy Director for State and Local 
                Affairs.
                    ``(B) Reporting.--The Deputy Director for Demand 
                Reduction, the Deputy Director for Supply Reduction, 
                and the Deputy Director for State and Local Affairs 
                shall report directly to the Deputy Director of the 
                Office of National Drug Control Policy.
                    ``(C) Deputy director for demand reduction.--The 
                Deputy Director for Demand Reduction shall be 
                responsible for the activities--
                            ``(i) in subparagraphs (A) through (H) of 
                        section 702(l); and
                            ``(ii) in section 709, the National Youth 
                        Anti-Drug Media Campaign Act.
                    ``(D) Deputy director for supply reduction.--The 
                Deputy Director for Supply Reduction shall be 
                responsible for the activities in subparagraphs (A) 
                through (C) in section 702(11).
                    ``(E) Deputy director for state and local 
                affairs.--The Deputy Director for State and Local 
                Affairs shall be responsible for the activities--
                            ``(i) in subparagraphs (A) through (D) of 
                        section 702(10);
                            ``(ii) in section 707, the High Intensity 
                        Drug Trafficking Areas Program; and
                            ``(iii) in section 708, the Counterdrug 
                        Technology Assessment Center.''.

SEC. 103. APPOINTMENT AND RESPONSIBILITIES OF THE DIRECTOR.

    (a) Succession.--Section 704(a) is amended by amending paragraph 
(3) to read as follows:
            ``(3) Acting director.--If the Director dies, resigns, or 
        is otherwise unable to perform the functions and duties of the 
        office, the Deputy Director shall perform the functions and 
        duties of the Director temporarily in an acting capacity 
        pursuant to subchapter III of chapter 33 of title 5, United 
        States Code.''.
    (b) Responsibilities.--Section 704(b) is amended--
            (1) in paragraph (4), by striking ``Federal departments and 
        agencies engaged in drug enforcement'' and inserting ``National 
        Drug Control Program agencies'';
            (2) in paragraph (7), by inserting after ``President'' the 
        following: ``and the appropriate congressional committees'';
            (3) in paragraph (13), by striking ``(beginning in 1999)'';
            (4) by striking paragraph (14) and inserting the following:
            ``(14) shall submit to the appropriate congressional 
        committees on an annual basis, not later than 60 days after the 
        date of the last day of the applicable period, a summary of--
                    ``(A) each of the evaluations received by the 
                Director under paragraph (13); and
                    ``(B) the progress of each National Drug Control 
                Program agency toward the drug control program goals of 
                the agency using the performance measures for the 
                agency developed under section 706(c);'';
            (5) in paragraph (15), by striking subparagraph (C) and 
        inserting the following:
                    ``(C) supporting the substance abuse information 
                clearinghouse administered by the Administrator of the 
                Substance Abuse and Mental Health Services 
                Administration and established in section 501(d)(16) of 
                the Public Health Service Act by--
                            ``(i) encouraging all National Drug Control 
                        Program agencies to provide all appropriate and 
                        relevant information; and
                            ``(ii) supporting the dissemination of 
                        information to all interested entities;''; and
            (6) by inserting at the end the following:
            ``(16) shall coordinate with the private sector to promote 
        private research and development of medications to treat 
        addiction;
            ``(17) shall seek the support and commitment of State and 
        local officials in the formulation and implementation of the 
        National Drug Control Strategy;
            ``(18) shall monitor and evaluate the allocation of 
        resources among Federal law enforcement agencies in response to 
        significant local and regional drug trafficking and production 
        threats; and
            ``(19) shall submit an annual report to Congress detailing 
        how the Office of National Drug Control Policy has consulted 
        with and assisted State and local governments with respect to 
        the formulation and implementation of the National Drug Control 
        Strategy and other relevant issues.''.
    (c) Review and Certification of National Drug Control Program 
Budget.--Section 704(c)(3) is amended--
            (1) in subparagraph (C)(iii), by inserting ``and the 
        appropriate congressional committees,'' after ``House of 
        Representatives''; and
            (2) in subparagraph (D)(ii)(II)(bb), by inserting ``and the 
        appropriate congressional committees,'' after ``House of 
        Representatives''.
    (d) Powers of Director.--Section 704(d) is amended--
            (1) in paragraph (9)--
                    (A) by inserting ``notwithstanding any other 
                provision of law,'' after ``(9)''; and
                    (B) by striking ``Strategy; and'' and inserting 
                ``Strategy and notify the appropriate congressional 
                committees of any fund control notice issued in 
                accordance with section 704(f)(5);''; and
            (2) in paragraph (10), by inserting before the period the 
        following: ``and section 706 of the Department of State 
        Authorization Act for Fiscal Year 2003 (22 U.S.C. 229j-1)''.
    (e) Fund Control Notices.--Section 704(f) is amended by adding at 
the end the following:
            ``(4) Congressional notice.--A copy of each fund control 
        notice shall be transmitted to the appropriate congressional 
        committees.
            ``(5) Restrictions.--The Director shall not issue a fund 
        control notice to direct that all or part of an amount 
        appropriated to the National Drug Control Program agency 
        account be obligated, modified, or altered in any manner--
                    ``(A) contrary, in whole or in part, to a specific 
                appropriation; or
                    ``(B) contrary, in whole or in part, to the 
                expressed intent of Congress.''.
    (f) United States Interdiction Coordinator.--
            (1) In general.--Section 704 is amended by adding at the 
        end the following:
    ``(i) United States Interdiction Coordinator.--
            ``(1) In general.--There shall be a United States 
        Interdiction Coordinator, who shall be designated by the 
        Director and who shall be responsible for the coordination of 
        interdiction operations among National Drug Control Program 
        agencies to prevent and reduce the illegal importation of drugs 
        into the United States.
            ``(2) Responsibilities.--The United States Interdiction 
        Coordinator shall be responsible to the Director for--
                    ``(A) coordinating the interdiction activities of 
                the National Drug Control Program agencies to ensure 
                consistency with the National Drug Control Strategy;
                    ``(B) developing a National Drug Control 
                Interdiction plan to ensure consistency with the 
                National Drug Control Strategy;
                    ``(C) assessing the sufficiency of assets of the 
                National Drug Control Program agencies committed to 
                illicit drug interdiction; and
                    ``(D) advising the Director on the efforts of each 
                National Drug Control Program Agency to implement the 
                National Drug Control Interdiction plan.''.
            (2) Amendment to homeland security act of 2002.--Section 
        878 of the Homeland Security Act of 2002 (6 U.S.C. 458) is 
        amended by striking ``shall--'' through paragraph (2) and 
        inserting ``shall ensure the adequacy of resources within the 
        Department for illicit drug interdiction.''.

SEC. 104. AMENDMENTS TO ENSURE COORDINATION WITH OTHER AGENCIES.

    Section 705 is amended--
            (1) in subsection (a)(1)(A), by striking ``abuse'';
            (2) by amending subsection (a)(3) to read as follows:
            ``(3) Required reports.--
                    ``(A) Secretaries of the interior and 
                agriculture.--Not later than July 1 of each year, the 
                Secretaries of Agriculture and the Interior shall 
                jointly submit to the Director and the appropriate 
                congressional committees an assessment of the quantity 
                of illegal drug cultivation and manufacturing in the 
                United States on lands owned or under the jurisdiction 
                of the Federal Government for the preceding year.
                    ``(B) Secretary of homeland security.--Not later 
                than July 1 of each year, the Secretary of Homeland 
                Security shall submit to the Director and the 
                appropriate congressional committees information for 
                the preceding year regarding--
                            ``(i) the number and type of seizures of 
                        drugs by each component of the Department of 
                        Homeland Security seizing drugs, as well as 
                        statistical information on the geographic areas 
                        of such seizures; and
                            ``(ii) the number of air and maritime 
                        patrol hours primarily dedicated to drug supply 
                        reduction missions undertaken by each component 
                        of the Department of Homeland Security.
                    ``(C) Secretary of defense.--The Secretary of 
                Defense shall, by July 1 of each year, submit to the 
                Director and the appropriate congressional committees 
                information for the preceding year regarding the number 
                of air and maritime patrol hours primarily dedicated to 
                drug supply reduction missions undertaken by each 
                component of the Department of Defense.''; and
            (3) in subsection (b)(2)(B), by striking ``Program'' and 
        inserting ``Strategy''.

SEC. 105. BUDGETARY MATTERS.

    (a) Submission of Drug Control Budget Requests.--Section 704(c)(1) 
is amended by adding at the end the following:
                    ``(C) Content of drug control budget requests.--A 
                drug control budget request submitted by a department, 
                agency, or program under this paragraph shall include 
                all requests for funds for any drug control activity 
                undertaken by that department, agency, or program, 
                including demand reduction, supply reduction, and State 
                and local affairs, including any drug law enforcement 
                activities. If an activity has both drug control and 
                nondrug control purposes or applications, the 
                department, agency, or program shall estimate by a 
                documented calculation the total funds requested for 
                that activity that would be used for drug control, and 
                shall set forth in its request the basis and method for 
                making the estimate.''.
    (b) National Drug Control Budget Proposal.--
            (1) National organizations.--Section 704(c)(2) is amended 
        by inserting ``and the head of each major national organization 
        that represents law enforcement officers, agencies, or 
        associations'' after ``agency''.
            (2) Total budget.--Section 704(c)(2)(A) is amended by 
        inserting before the semicolon: ``and to inform Congress and 
        the public about the total amount proposed to be spent on all 
        supply reduction, demand reduction, State and local affairs, 
        including any drug law enforcement, and other drug control 
        activities by the Federal Government, which shall conform to 
        the content requirements set forth in paragraph (1)(C)''.
    (c) Review and Certification of National Drug Control Program 
Budget.--Section 704(c)(3) is amended--
            (1) by redesignating subparagraphs (C) and (D) as 
        subparagraphs (D) and (E), respectively;
            (2) by inserting after subparagraph (B) the following new 
        subparagraph:
                    ``(C) Specific requests.--The Director shall not 
                confirm the adequacy of any budget request that--
                            ``(i) requests funding for Federal law 
                        enforcement activities that do not adequately 
                        compensate for transfers of drug enforcement 
                        resources and personnel to law enforcement and 
                        investigation activities;
                            ``(ii) requests funding for law enforcement 
                        activities on the borders of the United States 
                        that do not adequately direct resources to drug 
                        interdiction and enforcement;
                            ``(iii) requests funding for drug treatment 
                        activities that do not provide adequate results 
                        and accountability measures;
                            ``(iv) requests funding for any activities 
                        of the Safe and Drug-Free Schools Program that 
                        do not include a clear antidrug message or 
                        purpose intended to reduce drug use;
                            ``(v) requests funding for drug treatment 
                        activities that do not adequately support and 
                        enhance Federal drug treatment programs and 
                        capacity;
                            ``(vi) requests funding for fiscal year 
                        2007 for activities of the Department of 
                        Education, unless it is accompanied by a report 
                        setting forth a plan for providing expedited 
                        consideration of student loan applications for 
                        all individuals who submitted an application 
                        for any Federal grant, loan, or work assistance 
                        that was rejected or denied pursuant to 
                        484(r)(1) of the Higher Education Act of 1965 
                        (20 U.S.C. 1091(r)(1)) by reason of a 
                        conviction for a drug-related offense not 
                        occurring during a period of enrollment for 
                        which the individual was receiving any Federal 
                        grant, loan, or work assistance; and
                            ``(vii) requests funding for the operations 
                        and management of the Department of Homeland 
                        Security that does not include a specific 
                        request for funds for the Office of 
                        Counternarcotics Enforcement to carry out its 
                        responsibilities under section 878 of the 
                        Homeland Security Act of 2002 (6 U.S.C. 
                        458).'';
            (3) in subparagraph (D)(iii), as so redesignated, by 
        inserting ``and the appropriate congressional committees'' 
        after ``House of Representatives''; and
            (4) in subparagraph (E)(ii)(II)(bb), as so redesignated, by 
        inserting ``and the appropriate congressional committees'' 
        after ``House of Representatives''.
    (d) Powers of Director.--Section 704(d) is amended--
            (1) in paragraph (8)(D), by striking ``have been authorized 
        by Congress;'' and inserting ``authorized by law;'';
            (2) in paragraph (9)--
                    (A) by inserting ``notwithstanding any other 
                provision of law,'' after ``(9)''; and
                    (B) by striking ``Strategy; and'' and inserting 
                ``Strategy and notify the appropriate congressional 
                committees of any fund control notice issued;'';
            (3) in paragraph (10), by striking ``(22 U.S.C. 2291j).'' 
        and inserting ``(22 U.S.C. 2291j) and section 706 of the 
        Foreign Relations Authorization Act, Fiscal Year 2003 (22 
        U.S.C. 2291j-1); and''; and
            (4) by adding at the end the following new paragraph:
            ``(11) not later than August 1 of each year, submit to the 
        President a report, and transmit copies of the report to the 
        Secretary of State and the appropriate congressional 
        committees, that--
                    ``(A) provides the Director's assessment of which 
                countries are major drug transit countries or major 
                illicit drug producing countries as defined in section 
                481(e) of the Foreign Assistance Act of 1961 (22 U.S.C. 
                2291(e));
                    ``(B) provides the Director's assessment of whether 
                each country identified under subparagraph (A) has 
                cooperated fully with the United States or has taken 
                adequate steps on its own to achieve full compliance 
                with the goals and objectives established by the United 
                Nations Convention Against Illicit Traffic in Narcotic 
                Drugs and Psychotropic Substances and otherwise has 
                assisted in reducing the supply of illicit drugs to the 
                United States; and
                    ``(C) provides the Director's assessment of whether 
                application of procedures set forth in section 490 of 
                the Foreign Assistance Act of 1961 (22 U.S.C. 2291j), 
                as provided in section 706 of the Foreign Relations 
                Authorization Act, Fiscal Year 2003 (22 U.S.C. 2291j-
                1), is warranted with respect to countries the Director 
                assesses have not cooperated fully.''.
    (e) Fund Control Notices.--Section 704(f) (21 U.S.C. 1703(f)) is 
amended by adding at the end the following:
            ``(4) Congressional notice.--A copy of each fund control 
        notice shall be transmitted to the appropriate congressional 
        committees.
            ``(5) Restrictions.--The Director shall not issue a fund 
        control notice to direct that all or part of an amount 
        appropriated to the National Drug Control Program agency 
        account be obligated, modified, or altered in any manner 
        contrary, in whole or in part, to a specific appropriation or 
        statute.''.

              TITLE II--THE NATIONAL DRUG CONTROL STRATEGY

SEC. 201. ANNUAL PREPARATION AND SUBMISSION OF NATIONAL DRUG CONTROL 
              STRATEGY.

    Section 706 is amended to read as follows:

``SEC. 706. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, AND ASSESSMENT OF 
              NATIONAL DRUG CONTROL STRATEGY.

    ``(a) Timing, Contents, and Process for Development and Submission 
of National Drug Control Strategy.--
            ``(1) Timing.--Not later than February 1 of each year, the 
        President shall submit to Congress a National Drug Control 
        Strategy, which shall set forth a comprehensive plan for the 
        year to reduce drug abuse and the consequences of such drug 
        abuse in the United States by limiting the availability of, and 
        reducing the demand for, illegal drugs.
            ``(2) Contents.--
                    ``(A) In general.--The National Drug Control 
                Strategy submitted under paragraph (1) shall include--
                            ``(i) comprehensive, research-based, long-
                        range, quantifiable goals for reducing drug 
                        abuse and the consequences of drug abuse in the 
                        United States;
                            ``(ii) annual quantifiable and measurable 
                        objectives and specific targets to accomplish 
                        long-term quantifiable goals that the Director 
                        determines may be achieved during each year 
                        beginning on the date on which the National 
                        Drug Control Strategy is submitted;
                            ``(iii) 5-year projections for program and 
                        budget priorities;
                            ``(iv) a review of international, State, 
                        local, and private sector drug control 
                        activities to ensure that the United States 
                        pursues coordinated and effective drug control 
                        at all levels of government;
                            ``(v) an assessment of current illicit drug 
                        use (including inhalants) and availability, 
                        impact of illicit drug use, and treatment 
                        availability, which assessment shall include--
                                    ``(I) estimates of drug prevalence 
                                and frequency of use as measured by 
                                national, State, and local surveys of 
                                illicit drug use and by other special 
                                studies of nondependent and dependent 
                                illicit drug use;
                                    ``(II) illicit drug use in the 
                                workplace and the productivity lost by 
                                such use; and
                                    ``(III) illicit drug use by 
                                arrestees, probationers, and parolees;
                            ``(vi) an assessment of the reduction of 
                        illicit drug availability, as measured by--
                                    ``(I) the quantities of cocaine, 
                                heroin, marijuana, methamphetamine, 
                                ecstasy, and other drugs available for 
                                consumption in the United States;
                                    ``(II) the amount of marijuana, 
                                cocaine, heroin, methamphetamine, 
                                ecstasy, and precursor chemicals and 
                                other drugs entering the United States;
                                    ``(III) the number of illicit drug 
                                manufacturing laboratories seized and 
                                destroyed and the number of hectares of 
                                marijuana, poppy, and coca cultivated 
                                and destroyed domestically and in other 
                                countries;
                                    ``(IV) the number of metric tons of 
                                marijuana, heroin, cocaine, and 
                                methamphetamine seized and other drugs; 
                                and
                                    ``(V) changes in the price and 
                                purity of heroin, methamphetamine, and 
                                cocaine, changes in the price of 
                                ecstasy, and changes in 
                                tetrahydrocannabinol level of marijuana 
                                and other drugs;
                            ``(vii) an assessment of the reduction of 
                        the consequences of illicit drug use and 
                        availability, which shall include--
                                    ``(I) the burden illicit drug users 
                                placed on hospital emergency 
                                departments in the United States, such 
                                as the quantity of illicit drug-related 
                                services provided;
                                    ``(II) the annual national health 
                                care cost of illicit drug use; and
                                    ``(III) the extent of illicit drug-
                                related crime and criminal activity;
                            ``(viii) a determination of the status of 
                        drug treatment in the United States, by 
                        assessing--
                                    ``(I) public and private treatment 
                                utilization; and
                                    ``(II) the number of illicit drug 
                                users the Director estimates meet 
                                diagnostic criteria for treatment;
                            ``(ix) a review of the research agenda of 
                        the Counterdrug Technology Assessment Center to 
                        reduce the availability and abuse of drugs; and
                            ``(x) a summary of the efforts made to 
                        coordinate with private sector entities to 
                        conduct private research and development of 
                        medications to treat addiction by--
                                    ``(I) screening chemicals for 
                                potential therapeutic value;
                                    ``(II) developing promising 
                                compounds;
                                    ``(III) conducting clinical trials;
                                    ``(IV) seeking Food and Drug 
                                Administration approval for drugs to 
                                treat addiction;
                                    ``(V) marketing the drug for the 
                                treatment of addiction;
                                    ``(VI) urging physicians to use the 
                                drug in the treatment of addiction; and
                                    ``(VII) encouraging insurance 
                                companies to reimburse the cost of the 
                                drug for the treatment of addiction.
                    ``(B) Classified information.--Any contents of the 
                National Drug Control Strategy that involve information 
                properly classified under criteria established by an 
                Executive order shall be presented to Congress 
                separately from the rest of the National Drug Control 
                Strategy.
            ``(3) Process for development and submission.--In 
        developing and effectively implementing the National Drug 
        Control Strategy, the Director--
                    ``(A) shall consult with--
                            ``(i) the heads of the National Drug 
                        Control Program agencies;
                            ``(ii) Congress;
                            ``(iii) State and local officials;
                            ``(iv) private citizens and organizations 
                        with experience and expertise in demand 
                        reduction;
                            ``(v) private citizens and organizations 
                        with experience and expertise in supply 
                        reduction; and
                            ``(vi) appropriate representatives of 
                        foreign governments;
                    ``(B) in satisfying the requirements of 
                subparagraph (A), shall ensure, to the maximum extent 
                possible, that State and local officials and relevant 
                private organizations commit to support and take steps 
                to achieve the goals and objectives of the National 
                Drug Control Strategy;
                    ``(C) with the concurrence of the Attorney General, 
                may require the El Paso Intelligence Center to 
                undertake specific tasks or projects to support or 
                implement the National Drug Control Strategy; and
                    ``(D) with the concurrence of the Director of 
                National Intelligence and the Attorney General, may 
                request that the National Drug Intelligence Center 
                undertake specific tasks or projects to support or 
                implement the National Drug Control Strategy.
    ``(b) Submission of Revised Strategy.--The President may submit to 
Congress a revised National Drug Control Strategy that meets the 
requirements of this section--
            ``(1) at any time, upon a determination of the President, 
        in consultation with the Director, that the National Drug 
        Control Strategy in effect is not sufficiently effective; or
            ``(2) if a new President or Director takes office.''.

SEC. 202. PERFORMANCE MEASUREMENTS.

    Section 706 is amended by adding at the end the following:
    ``(c) Performance Measurement System.--Not later than February 1 of 
each year, the Director shall submit to Congress as part of the 
National Drug Control Strategy, a description of a national drug 
control performance measurement system, that--
            ``(1) develops 2-year and 5-year performance measures and 
        targets for each National Drug Control Strategy goal and 
        objective established for reducing drug use, availability, and 
        the consequences of drug use;
            ``(2) describes the sources of information and data that 
        will be used for each performance measure incorporated into the 
        performance measurement system;
            ``(3) identifies major programs and activities of the 
        National Drug Control Program agencies that support the goals 
        and annual objectives of the National Drug Control Strategy;
            ``(4) evaluates the contribution of demand reduction and 
        supply reduction activities as defined in section 702 
        implemented by each National Drug Control Program agency in 
        support of the National Drug Control Strategy;
            ``(5) monitors consistency between the drug-related goals 
        and objectives of the National Drug Control Program agencies 
        and ensures that each agency's goals and budgets support and 
        are fully consistent with the National Drug Control Strategy; 
        and
            ``(6) coordinates the development and implementation of 
        national drug control data collection and reporting systems to 
        support policy formulation and performance measurement, 
        including an assessment of--
                    ``(A) the quality of current drug use measurement 
                instruments and techniques to measure supply reduction 
                and demand reduction activities;
                    ``(B) the adequacy of the coverage of existing 
                national drug use measurement instruments and 
                techniques to measure the casual drug use population, 
                the addicted drug user population, and groups that are 
                at risk for drug use;
                    ``(C) the adequacy of the coverage of existing 
                national treatment outcome monitoring systems to 
                measure the effectiveness of drug abuse treatment in 
                reducing drug use and criminal behavior during and 
                after the completion of substance abuse treatment; and
                    ``(D) the actions the Director shall take to 
                correct any deficiencies and limitations identified 
                pursuant to subparagraphs (A) and (B) of this 
                subsection.
    ``(d) Modifications.--A description of any modifications made 
during the preceding year to the national drug performance measurement 
system described in subsection (c) shall be included in each report 
submitted under subsection (b).''.

SEC. 203. ANNUAL REPORT REQUIREMENT.

    (a) In General.--On or before February 1 of each year, the Director 
shall submit a report to Congress that describes--
            (1) the strategy of the national media campaign and whether 
        specific objectives of the campaign were accomplished;
            (2) steps taken to ensure that the national media campaign 
        operates in an effective and efficient manner consistent with 
        the overall strategy and focus of the campaign;
            (3) plans to purchase advertising time and space;
            (4) policies and practices implemented to ensure that 
        Federal funds are used responsibly to purchase advertising time 
        and space and eliminate the potential for waste, fraud, and 
        abuse;
            (5) all contracts entered into with a corporation, 
        partnership, or individual working on behalf of the national 
        media campaign;
            (6) specific policies and steps implemented to ensure 
        compliance with title IV of this Act;
            (7) steps taken to ensure that the national media campaign 
        will secure, to the maximum extent possible, no cost matches of 
        advertising time and space or in-kind contributions that are 
        directly related to the campaign in accordance with title IV of 
        this Act; and
            (8) a review and evaluation of the effectiveness of the 
        national media campaign strategy for the past year.
    (b) Audit.--The Government Accountability Office shall, at a 
frequency of not less than once per year--
            (1) conduct and supervise an audit and investigation 
        relating to the programs and operations of the--
                    (A) Office; or
                    (B) certain programs within the Office, including--
                            (i) the High Intensity Drug Trafficking 
                        Areas Program;
                            (ii) the Counterdrug Technology Assessment 
                        Center; or
                            (iii) the National Youth Anti-drug Media 
                        Campaign; and
            (2) provide the Director and the appropriate congressional 
        committees with a report containing an evaluation of and 
        recommendations on the--
                    (A) policies and activities of the programs and 
                operations subject to the audit and investigation;
                    (B) economy, efficiency, and effectiveness in the 
                administration of the reviewed programs and operations; 
                and
                    (C) policy or management changes needed to prevent 
                and detect fraud and abuse in such programs and 
                operations.

            TITLE III--HIGH INTENSITY DRUG TRAFFICKING AREAS

SEC. 301. HIGH INTENSITY DRUG TRAFFICKING AREAS PROGRAM.

    Section 707 is amended to read as follows:

``SEC. 707. HIGH INTENSITY DRUG TRAFFICKING AREAS PROGRAM.

    ``(a) Establishment.--
            ``(1) In general.--There is established in the Office a 
        program to be known as the High Intensity Drug Trafficking 
        Areas Program (in this section referred to as the `Program').
            ``(2) Purpose.--The purpose of the Program is to reduce 
        drug trafficking and drug production in the United States by--
                    ``(A) facilitating cooperation among Federal, 
                State, and local law enforcement agencies to share 
                information and implement coordinated enforcement 
                activities;
                    ``(B) enhancing intelligence sharing among Federal, 
                State, and local law enforcement agencies;
                    ``(C) providing reliable intelligence to law 
                enforcement agencies needed to design effective 
                enforcement strategies and operations; and
                    ``(D) supporting coordinated law enforcement 
                strategies which maximize use of available resources to 
                reduce the supply of illegal drugs in designated areas 
                and in the United States as a whole.
    ``(b) Designation.--
            ``(1) In general.--The Director, in consultation with the 
        Attorney General, the Secretary of the Treasury, the Secretary 
        of Homeland Security, heads of the National Drug Control 
        Program agencies, and the Governor of each applicable State, 
        may designate any specified area of the United States as a high 
        intensity drug trafficking area.
            ``(2) Activities.--After making a designation under 
        paragraph (1) and in order to provide Federal assistance to the 
        area so designated, the Director may--
                    ``(A) obligate such sums as are appropriated for 
                the Program;
                    ``(B) direct the temporary reassignment of Federal 
                personnel to such area, subject to the approval of the 
                head of the department or agency that employs such 
                personnel;
                    ``(C) take any other action authorized under 
                section 704 to provide increased Federal assistance to 
                those areas; and
                    ``(D) coordinate activities under this section 
                (specifically administrative, recordkeeping, and funds 
                management activities) with State and local officials.
    ``(c) Petitions for Designation.--The Director shall establish 
regulations under which a coalition of interested law enforcement 
agencies from an area may petition for designation as a high intensity 
drug trafficking area. Such regulations shall provide for a regular 
review by the Director of the petition, including a recommendation 
regarding the merit of the petition to the Director by a panel of 
qualified, independent experts.
    ``(d) Factors for Consideration.--In considering whether to 
designate an area under this section as a high intensity drug 
trafficking area, the Director shall consider, in addition to such 
other criteria as the Director considers to be appropriate, the extent 
to which--
            ``(1) the area is a significant center of illegal drug 
        production, manufacturing, importation, or distribution;
            ``(2) State and local law enforcement agencies have 
        committed resources to respond to the drug trafficking problem 
        in the area, thereby indicating a determination to respond 
        aggressively to the problem;
            ``(3) drug-related activities in the area are having a 
        significant harmful impact in the area, and in other areas of 
        the country; and
            ``(4) a significant increase in allocation of Federal 
        resources is necessary to respond adequately to drug-related 
        activities in the area.
    ``(e) Organization of High Intensity Drug Trafficking Areas.--
            ``(1) Executive board and officers.--To be eligible for 
        funds appropriated under this section, each high intensity drug 
        trafficking area shall be governed by an Executive Board. The 
        Executive Board shall designate a chairman, vice chairman, and 
        any other officers to the Executive Board that it determines 
        are necessary.
            ``(2) Responsibilities.--The Executive Board of a high 
        intensity drug trafficking area shall be responsible for--
                    ``(A) providing direction and oversight in 
                establishing and achieving the goals of the high 
                intensity drug trafficking area;
                    ``(B) managing the funds of the high intensity drug 
                trafficking area;
                    ``(C) reviewing and approving all funding proposals 
                consistent with the overall objective of the high 
                intensity drug trafficking area; and
                    ``(D) reviewing and approving all reports to the 
                Director on the activities of the high intensity drug 
                trafficking area.
            ``(3) Board representation.--None of the funds appropriated 
        under this section may be expended for any high intensity drug 
        trafficking area, or for a partnership or region of a high 
        intensity drug trafficking area, if the Executive Board for 
        such area, region, or partnership, does not apportion an equal 
        number of votes between representatives of participating 
        Federal agencies and representatives of participating State and 
        local agencies. Where it is impractical for an equal number of 
        representatives of Federal agencies and State and local 
        agencies to attend a meeting of an Executive Board in person, 
        the Executive Board may use a system of proxy votes or weighted 
        votes to achieve the voting balance required by this paragraph.
            ``(4) No agency relationship.--The eligibility requirements 
        of this section are intended to ensure the responsible use of 
        Federal funds. Nothing in this section is intended to create an 
        agency relationship between individual high intensity drug 
        trafficking areas and the Federal Government.
    ``(f) Use of Funds.--The Director shall ensure that no Federal 
funds appropriated for the Program are expended for the establishment 
or expansion of drug treatment programs, and shall ensure that not more 
than 5 percent of the Federal funds appropriated for the Program are 
expended for the establishment of drug prevention programs.
    ``(g) Counterterrorism Activities.--
            ``(1) Assistance authorized.--The Director may authorize 
        use of resources available for the Program to assist Federal, 
        State, and local law enforcement agencies in investigations and 
        activities related to terrorism and prevention of terrorism, 
        especially but not exclusively with respect to such 
        investigations and activities that are also related to drug 
        trafficking.
            ``(2) Limitation.--The Director shall ensure--
                    ``(A) that assistance provided under paragraph (1) 
                remains incidental to the purpose of the Program to 
                reduce drug availability and carry out drug-related law 
                enforcement activities; and
                    ``(B) that significant resources of the Program are 
                not redirected to activities exclusively related to 
                terrorism, except on a temporary basis under 
                extraordinary circumstances, as determined by the 
                Director.
    ``(h) Role of Drug Enforcement Administration.--The Director, in 
consultation with the Attorney General, shall ensure that a 
representative of the Drug Enforcement Administration is included in 
the Intelligence Support Center for each high intensity drug 
trafficking area.
    ``(i) Annual HIDTA Program Budget Submissions.--As part of the 
documentation that supports the President's annual budget request for 
the Office, the Director shall submit to Congress a budget 
justification that includes--
            ``(1) the amount requested for each high intensity drug 
        trafficking area, with supporting narrative descriptions and 
        rationale for each request; and
            ``(2) a detailed justification for each funding request 
        that explains--
                    ``(A) the reasons for the requested funding level; 
                how such funding level was determined based on a 
                current assessment of the drug trafficking threat in 
                each high intensity drug trafficking area;
                    ``(B) how such funding will ensure that the goals 
                and objectives of each such area will be achieved; and
                    ``(C) how such funding supports the National Drug 
                Control Strategy.
    ``(j) Emerging Threat Response Fund.--
            ``(1) In general.--Subject to the availability of 
        appropriations, the Director may expend up to 10 percent of the 
        amounts appropriated under this section on a discretionary 
        basis, to respond to any emerging drug trafficking threat in an 
        existing high intensity drug trafficking area, or to establish 
        a new high intensity drug trafficking area or expand an 
        existing high intensity drug trafficking area, in accordance 
        with the criteria established under paragraph (2).
            ``(2) Consideration of impact.--In allocating funds under 
        this subsection, the Director shall consider--
                    ``(A) the impact of activities funded on reducing 
                overall drug traffic in the United States, or 
                minimizing the probability that an emerging drug 
                trafficking threat will spread to other areas of the 
                United States; and
                    ``(B) such other criteria as the Director considers 
                appropriate.
    ``(k) Evaluation.--
            ``(1) Initial report.--Not later than 90 days after the 
        date of the enactment of this section, the Director shall, 
        after consulting with the Executive Boards of each designated 
        high intensity drug trafficking area, submit a report to 
        Congress that describes, for each designated high intensity 
        drug trafficking area--
                    ``(A) the specific purposes for the high intensity 
                drug trafficking area;
                    ``(B) the specific long-term and short-term goals 
                and objectives for the high intensity drug trafficking 
                area;
                    ``(C) the measurements that will be used to 
                evaluate the performance of the high intensity drug 
                trafficking area in achieving the long-term and short-
                term goals; and
                    ``(D) the reporting requirements needed to evaluate 
                the performance of the high intensity drug trafficking 
                area in achieving the long-term and short-term goals.
            ``(2) Evaluation of hidta program as part of national drug 
        control strategy.--For each designated high intensity drug 
        trafficking area, the Director shall submit, as part of the 
        annual National Drug Control Strategy report, a report that--
                    ``(A) describes--
                            ``(i) the specific purposes for the high 
                        intensity drug trafficking area; and
                            ``(ii) the specific long-term and short-
                        term goals and objectives for the high 
                        intensity drug trafficking area; and
                    ``(B) includes an evaluation of the performance of 
                the high intensity drug trafficking area in 
                accomplishing the specific long-term and short-term 
                goals and objectives identified under paragraph (1)(B).
    ``(l) Assessment of Drug Enforcement Task Forces in High Intensity 
Drug Trafficking Areas.--Not later than 180 days after the date of 
enactment of this subsection, and as part of each subsequent annual 
National Drug Control Strategy report, the Director shall submit to 
Congress a report--
            ``(1) assessing the number and operation of all federally 
        funded drug enforcement task forces within each high intensity 
        drug trafficking area; and
            ``(2) describing--
                    ``(A) each Federal, State, and local drug 
                enforcement task force operating in the high intensity 
                drug trafficking area;
                    ``(B) how such task forces coordinate with each 
                other, with any high intensity drug trafficking area 
                task force, and with investigations receiving funds 
                from the Organized Crime and Drug Enforcement Task 
                Force;
                    ``(C) what steps, if any, each such task force 
                takes to share information regarding drug trafficking 
                and drug production with other federally funded drug 
                enforcement task forces in the high intensity drug 
                trafficking area;
                    ``(D) the role of the high intensity drug 
                trafficking area in coordinating the sharing of such 
                information among task forces;
                    ``(E) the nature and extent of cooperation by each 
                Federal, State, and local participant in ensuring that 
                such information is shared among law enforcement 
                agencies and with the high intensity drug trafficking 
                area;
                    ``(F) the nature and extent to which information 
                sharing and enforcement activities are coordinated with 
                joint terrorism task forces in the high intensity drug 
                trafficking area; and
                    ``(G) any recommendations for measures needed to 
                ensure that task force resources are utilized 
                efficiently and effectively to reduce the availability 
                of illegal drugs in the high intensity drug trafficking 
                areas.
    ``(m) Assessment of Intelligence Sharing in High Intensity Drug 
Trafficking Areas Program.--Not later than 180 days after the date of 
the enactment of this section, and as part of each subsequent annual 
National Drug Control Strategy report, the Director, in consultation 
with the Director of National Intelligence, shall submit to Congress a 
report--
            ``(1) evaluating existing and planned intelligence systems 
        supported by each high intensity drug trafficking area, or 
        utilized by task forces receiving any funding under the 
        Program, including the extent to which such systems ensure 
        access and availability of intelligence to Federal, State, and 
        local law enforcement agencies within the high intensity drug 
        trafficking area and outside of it;
            ``(2) the extent to which Federal, State, and local law 
        enforcement agencies participating in each high intensity drug 
        trafficking area are sharing intelligence information to assess 
        current drug trafficking threats and design appropriate 
        enforcement strategies; and
            ``(3) the measures needed to improve effective sharing of 
        information and intelligence regarding drug trafficking and 
        drug production among Federal, State, and local law enforcement 
        participating in a high intensity drug trafficking area, and 
        between such agencies and similar agencies outside the high 
        intensity drug trafficking area.
    ``(n) Coordination of Intelligence Sharing With Organized Crime 
Drug Enforcement Task Force Program.--The Director, in consultation 
with the Attorney General, shall ensure that any drug enforcement 
intelligence obtained by the Intelligence Support Center for each high 
intensity drug trafficking area is shared, on a timely basis, with the 
drug intelligence fusion center operated by the Organized Crime Drug 
Enforcement Task Force of the Department of Justice.
    ``(o) Use of Funds To Combat Methamphetamine Trafficking.--
            ``(1) In general.--
                    ``(A) Requirement.--The Director shall ensure that, 
                of the amounts appropriated for a fiscal year for the 
                Program, at least $15,000,000 is allocated to combat 
                the trafficking of methamphetamine in areas designated 
                by the Director as high intensity drug trafficking 
                areas.
                    ``(B) Activities.--In meeting the requirement in 
                subparagraph (A), the Director shall transfer funds to 
                appropriate Federal, State, and local governmental 
                agencies for employing additional Federal law 
                enforcement personnel, or facilitating the employment 
                of additional State and local law enforcement 
                personnel, including agents, investigators, 
                prosecutors, laboratory technicians, chemists, 
                investigative assistants, and drug prevention 
                specialists.
            ``(2) Apportionment of funds.--
                    ``(A) Factors in apportionment.--The Director shall 
                apportion amounts allocated under paragraph (1) among 
                areas designated by the Director as high intensity drug 
                trafficking areas based on the following factors:
                            ``(i) The number of methamphetamine 
                        manufacturing facilities discovered by Federal, 
                        State, or local law enforcement officials in 
                        the area during the previous fiscal year.
                            ``(ii) The number of methamphetamine 
                        prosecutions in Federal, State, or local courts 
                        in the area during the previous fiscal year.
                            ``(iii) The number of methamphetamine 
                        arrests by Federal, State, or local law 
                        enforcement officials in the area during the 
                        previous fiscal year.
                            ``(iv) The amounts of methamphetamine or 
                        listed chemicals (as that term is defined in 
                        section 102(33) of the Controlled Substances 
                        Act (21 U.S.C. 802(33)) seized by Federal, 
                        State, or local law enforcement officials in 
                        the area during the previous fiscal year.
                            ``(v) Intelligence and predictive data from 
                        the Drug Enforcement Administration showing 
                        patterns and trends in abuse, trafficking, and 
                        transportation in methamphetamine and listed 
                        chemicals (as that term is so defined).
                    ``(B) Certification.--Before the Director 
                apportions any funds under this paragraph to a high 
                intensity drug trafficking area, the Director shall 
                certify that the law enforcement entities responsible 
                for clandestine methamphetamine laboratory seizures in 
                that area are providing laboratory seizure data to the 
                national clandestine laboratory database at the El Paso 
                Intelligence Center.
    ``(p) Authorization of Appropriations.--There is authorized to be 
appropriated to the Office of National Drug Control Policy to carry out 
this section--
            ``(1) $280,000,000 for fiscal year 2007;
            ``(2) $290,000,000 for each of fiscal years 2008 and 2009; 
        and
            ``(3) $300,000,000 for each of fiscal years 2010 and 
        2011.''.

SEC. 302. FUNDING FOR CERTAIN HIGH INTENSITY DRUG TRAFFICKING AREAS.

    (a) Short Title.--This section may be cited as the ``Dawson Family 
Community Protection Act''.
    (b) Findings.--Congress finds the following:
            (1) In the early morning hours of October 16, 2002, the 
        home of Carnell and Angela Dawson was firebombed in apparent 
        retaliation for Mrs. Dawson's notification to police about 
        persistent drug distribution activity in their East Baltimore 
        City neighborhood.
            (2) The arson claimed the lives of Mr. and Mrs. Dawson and 
        their 5 young children, aged 9 to 14.
            (3) The horrific murder of the Dawson family is a stark 
        example of domestic narco-terrorism.
            (4) In all phases of counternarcotics law enforcement--from 
        prevention to investigation to prosecution to reentry--the 
        voluntary cooperation of ordinary citizens is a critical 
        component.
            (5) Voluntary cooperation is difficult for law enforcement 
        officials to obtain when citizens feel that cooperation carries 
        the risk of violent retaliation by illegal drug trafficking 
        organizations and their affiliates.
            (6) Public confidence that law enforcement is doing all it 
        can to make communities safe is a prerequisite for voluntary 
        cooperation among people who may be subject to intimidation or 
        reprisal (or both).
            (7) Witness protection programs are insufficient on their 
        own to provide security because many individuals and families 
        who strive every day to make distressed neighborhoods livable 
        for their children, other relatives, and neighbors will resist 
        or refuse offers of relocation by local, State, and Federal 
        prosecutorial agencies and because, moreover, the continued 
        presence of strong individuals and families is critical to 
        preserving and strengthening the social fabric in such 
        communities.
            (8) Where (as in certain sections of Baltimore City) 
        interstate trafficking of illegal drugs has severe ancillary 
        local consequences within areas designated as high intensity 
        drug trafficking areas, it is important that supplementary High 
        Intensity Drug Trafficking Areas Program funds be committed to 
        support initiatives aimed at making the affected communities 
        safe for the residents of those communities and encouraging 
        their cooperation with local, State, and Federal law 
        enforcement efforts to combat illegal drug trafficking.
    (c) Funding for Certain High Intensity Drug Trafficking Areas.--
Section 707, as amended by section 301, is amended by adding at the end 
the following:
    ``(q) Specific Purposes.--
            ``(1) In general.--The Director shall ensure that, of the 
        amounts appropriated for a fiscal year for the Program, at 
        least $7,000,000 is used in high intensity drug trafficking 
        areas with severe neighborhood safety and illegal drug 
        distribution problems.
            ``(2) Required uses.--The funds used under paragraph (1) 
        shall be used--
                    ``(A) to ensure the safety of neighborhoods and the 
                protection of communities, including the prevention of 
                the intimidation of potential witnesses of illegal drug 
                distribution and related activities; and
                    ``(B) to combat illegal drug trafficking through 
                such methods as the Director considers appropriate, 
                such as establishing or operating (or both) a toll-free 
                telephone hotline for use by the public to provide 
                information about illegal drug-related activities.''.

SEC. 303. ASSESSMENT.

    The Director shall assess the ability of the HIDTA Program to 
respond to the so-called ``balloon effect'', whereby urban drug 
traffickers facing intensive law enforcement efforts expand and spread 
their trafficking and distribution into rural, suburban, and smaller 
urban areas by conducting a demonstration project examining the ability 
of the New York/New Jersey HIDTA, with its new single colocated 
Organized Crime and Drug Enforcement Task Force/High Intensity Drug 
Trafficking Area Strike Force and HIDTA Regional Intelligence Center, 
to address the movement of drug traffickers into the more rural, 
suburban, and smaller areas encompassed by the counties of Albany, 
Onondaga, Monroe, and Erie in New York State and by annexing these 
counties into the existing New York/New Jersey HIDTA.

                          TITLE IV--TECHNOLOGY

SEC. 401. COUNTERDRUG TECHNOLOGY ASSESSMENT CENTER.

    (a) Chief Scientist.--Section 708(b) is amended to read as follows:
    ``(b) Chief Scientist.--There shall be at the head of the Center 
the Chief Scientist, who shall be appointed by the Director from among 
individuals qualified and distinguished in the area of science, 
medicine, engineering, or technology.''.
    (b) Responsibilities.--
            (1) Research and development.--Section 708 is amended by--
                    (A) redesignating subsection (d) as subsection (e); 
                and
                    (B) striking subsection (c) and inserting the 
                following:
    ``(c) Research and Development Responsibilities.--The Chief 
Scientist shall be responsible to the Director for--
            ``(1) identifying and defining the short-, medium-, and 
        long-term scientific and technological needs of Federal, State, 
        and local drug supply reduction agencies, including--
                    ``(A) advanced surveillance, tracking, and radar 
                imaging;
                    ``(B) electronic support measures;
                    ``(C) communications;
                    ``(D) data fusion, advanced computer systems, and 
                artificial intelligence; and
                    ``(E) chemical, biological, radiological (including 
                neutron and electron), and other means of detection;
            ``(2) identifying demand reduction basic and applied 
        research needs and initiatives, in consultation with affected 
        National Drug Control Program agencies, including--
                    ``(A) improving treatment through neuroscientific 
                advances;
                    ``(B) improving the transfer of biomedical research 
                to the clinical setting; and
                    ``(C) in consultation with the National Institute 
                of Drug Abuse, and through interagency agreements or 
                grants, examining addiction and rehabilitation research 
                and the application of technology to expanding the 
                effectiveness and availability of drug treatment;
            ``(3) making a priority ranking of such needs identified in 
        paragraphs (1) and (2) according to fiscal and technological 
        feasibility, as part of a National Counterdrug Research and 
        Development Program;
            ``(4) overseeing and coordinating counterdrug technology 
        initiatives with related activities of other Federal civilian 
        and military departments;
            ``(5) providing support to the development and 
        implementation of the national drug control performance 
        measurement system established under subsection (c) of section 
        706; and
            ``(6) transferring funds made available to a National Drug 
        Control Program Agency for counterdrug technology research and 
        development to another account within such agency or to another 
        National Drug Control Program Agency for counterdrug technology 
        research and development, pursuant to the authority of the 
        Director under section 704.
    ``(d) Limitation on Authority.--The authority granted to the 
Director under this section shall not extend to the awarding of 
contracts, management of individual projects, or other operational 
activities.''.
            (2) Assistance and support.--Subsection (e) of section 708, 
        as redesignated by this section, is amended to read as follows:
    ``(e) Assistance and Support to the Office of National Drug Control 
Policy.--The Secretary of Defense, the Secretary of Homeland Security, 
and the Secretary of Health and Human Services shall, to the maximum 
extent practicable, render assistance and support to the Office and to 
the Director in the conduct of counterdrug technology assessment.''.
            (3) Technology transfer program.--Section 708 is amended by 
        adding at the end the following:
    ``(f) Technology Transfer Program.--
            ``(1) Program.--The Chief Scientist, with the advice and 
        counsel of experts from State and local law enforcement 
        agencies, shall be responsible to the Director for coordination 
        and implementation of a counterdrug technology transfer 
        program.
            ``(2) Purpose.--The purpose of the Technology Transfer 
        Program shall be for the Counterdrug Technology Assessment 
        Center to transfer technology and associated training directly 
        to State and local law enforcement agencies.
            ``(3) Priority of receipts.--Transfers shall be made in 
        priority order based on--
                    ``(A) the need of potential recipients for such 
                technology;
                    ``(B) the effectiveness of the technology to 
                enhance current counterdrug activities of potential 
                recipients; and
                    ``(C) the ability and willingness of potential 
                recipients to evaluate transferred technology.
            ``(4) Agreement authority.--The Director may enter into an 
        agreement with the Secretary of Homeland Security to transfer 
        technology with both counterdrug and homeland security 
        applications to State and local law enforcement agencies on a 
        reimbursable basis.
            ``(5) Report.--On or before July 1 of each year, the 
        Director shall submit a report to the appropriate congressional 
        committees which addresses the following:
                    ``(A) The number of requests received during the 
                previous 12 months.
                    ``(B) The number of requests fulfilled during the 
                previous 12 months.
                    ``(C) A summary of the criteria used in making the 
                determination on what requests were funded and what 
                requests were not funded.
                    ``(D) A general assessment of the future needs of 
                the program, based on expected changes in threats, 
                expected technologies, and likely need from potential 
                recipients.
                    ``(E) An assessment of the effectiveness of the 
                technologies transferred, based in part on the 
                evaluations provided by the recipients, with a 
                recommendation whether the technology should continue 
                to be offered through the program.''.

  TITLE V--REAUTHORIZATION AND IMPROVEMENT OF THE NATIONAL ANTI-DRUG 
                             MEDIA CAMPAIGN

SEC. 501. SHORT TITLE.

    This title may be cited as the ``National Youth Anti-Drug Media 
Campaign Reauthorization Act of 2006''.

SEC. 502. PURPOSES OF THE NATIONAL YOUTH ANTI-DRUG MEDIA CAMPAIGN.

    The Drug-Free Media Campaign Act of 1998 (21 U.S.C. 1801 et seq.) 
is amended--
            (1) in section 101, by striking ``Drug-Free Media Campaign 
        Act of 1998'' and inserting ``National Youth Anti-Drug Media 
        Campaign Act''; and
            (2) in section 102--
                    (A) in subsection (a), by striking ``national media 
                campaign'' and all that follows through the period and 
                inserting the following: ``national youth anti-drug 
                media campaign (referred to in this subtitle as the 
                `national media campaign') in accordance with this 
                subtitle for the purposes of--
            ``(1) preventing drug abuse among young people in the 
        United States;
            ``(2) increasing awareness of adults of the impact of drug 
        abuse on young people; and
            ``(3) encouraging parents and other interested adults to 
        discuss with young people the dangers of illegal drug use.''; 
        and
                    (B) in subsection (b), by striking ``105'' and 
                inserting ``104''.

SEC. 503. ROLES AND RESPONSIBILITIES OF THE DIRECTOR, THE PARTNERSHIP 
              FOR A DRUG-FREE AMERICA, AND A MEDIA BUYING CONTRACTOR.

    The Drug-Free Media Campaign Act of 1998 (21 U.S.C. 1801 et seq.) 
is amended--
            (1) by adding at the end the following:
    ``(c) Division of Responsibilities and Functions Under the 
Program.--
            ``(1) In general.--The Director, in consultation with the 
        Partnership for a Drug-Free America, shall determine the 
        overall purposes and strategy of the national media campaign.
            ``(2) Responsibilities.--
                    ``(A) Director.--The Director shall be responsible 
                for implementing a focused national media campaign to 
                meet the purposes set forth in section 102(a), and 
                shall approve--
                            ``(i) the strategy of the national media 
                        campaign;
                            ``(ii) all advertising and promotional 
                        material used in the national media campaign; 
                        and
                            ``(iii) the plan for the purchase of 
                        advertising time and space for the national 
                        media campaign.
                    ``(B) The partnership for a drug-free america.--The 
                Director shall request that the Partnership for a Drug-
                Free America--
                            ``(i) develop and recommend strategies to 
                        achieve the goals of the national media 
                        campaign, including addressing national and 
                        local drug threats in specific regions or 
                        States, such as methamphetamine and ecstasy;
                            ``(ii) create all advertising to be used in 
                        the national media campaign, except 
                        advertisements that are--
                                    ``(I) provided by other nonprofit 
                                entities pursuant to section 103(c);
                                    ``(II) intended to reach a 
                                minority, ethnic, or other special 
                                audience that cannot be obtained at no 
                                cost (not including production costs 
                                and talent reuse payments), provided 
                                that any such advertising material is 
                                reviewed by the Partnership for a Drug-
                                Free America; or
                                    ``(III) any other advertisements 
                                that the Partnership for a Drug-Free 
                                America determines it is unable to 
                                provide.
                    ``(C) Media buying contractor.--The Director shall 
                enter into a contract with a media buying contractor to 
                plan and purchase advertising time and space for the 
                national media campaign. The media buying contractor 
                shall not provide any service or material, or conduct 
                any function or activity which can be provided by the 
                Partnership for a Drug-Free America, as defined in 
                section 403(2)(B)''; and
            (2) in section 103--
                    (A) in subparagraph (A), by inserting ``, including 
                the strategic planning for, and accounting of, such 
                purchases'' after ``space'';
                    (B) in subparagraph (C), by striking ``out-of-
                pocket''; and
                    (C) in subparagraph (F), by striking ``the Office 
                of National Drug Control Policy'' and inserting 
                ``either the Office of National Drug Control Policy or 
                the designee of the Office''.

SEC. 504. RESPONSIBLE USE OF FEDERAL FUNDS FOR THE NATIONAL YOUTH ANTI-
              DRUG MEDIA CAMPAIGN.

    The Drug-Free Media Campaign Act of 1998 (21 U.S.C. 1801 et seq.) 
is amended--
            (1) in section 103, by striking paragraph (2) and inserting 
        the following:
            ``(2) Advertising.--
                    ``(A) In general.--Except as provided in 
                subparagraph (B), in carrying out this subtitle, the 
                Director shall ensure that sufficient funds are 
                allocated to meet the stated goals of the national 
                media campaign.
                    ``(B) Exception.--No funds shall be used for the 
                creative development of advertisements (not including 
                out-of-pocket production costs and talent reuse 
                payments) except when--
                            ``(i) the advertisements are intended to 
                        reach a minority, ethnic, or other special 
                        audience that cannot be obtained at no cost 
                        (not including production costs and talent 
                        reuse payments); or
                            ``(ii) the Partnership for a Drug-Free 
                        America, determines that it is unable to 
                        provide such advertisements.'';
            (2) in subsection (b), by striking ``105'' and inserting 
        ``104'';
            (3) by striking subsection (c) and inserting the following:
    ``(c) Matching Requirement.--
            ``(1) No cost match.--
                    ``(A) In general.--Except as provided in 
                subparagraph (B), amounts made available for the 
                national media campaign under section 106 shall be used 
                to require a no cost match of equivalent value of 
                advertising broadcast time, print space, or in-kind 
                contributions to the national media campaign.
                    ``(B) Exception.--The Director shall ensure that 
                all no cost matches of advertising material, time, 
                space, or in-kind contributions provided pursuant to 
                subparagraph (A) directly relate to substance abuse 
                prevention and specifically promote 1 or more of the 
                specific purposes set forth in section 102(a). This may 
                include antismoking messages that are produced by 
                nonprofit organizations and are targeted toward minors.
            ``(2) Sponsorship identification.--Any advertising material 
        donated to the national media campaign at no cost shall not be 
        subject to the sponsorship identification provisions in section 
        317 of the Communications Act of 1934 (47 U.S.C. 317).'';
            (4) by adding at the end the following:
    ``(d) Responsible Use of Federal Funds.--
            ``(1) In general.--The Director shall ensure that--
                    ``(A) for each fiscal year, not less than 77 
                percent of the amounts appropriated under this subtitle 
                shall be used for the activities allowed under section 
                103(a)(1)(A);
                    ``(B) no Federal funds provided under this subtitle 
                are used to pay any entity for any activity or service 
                that duplicates, in whole or in part, any material, 
                function, activity, or service provided by the 
                Partnership for a Drug-Free America, as defined in 
                section 403(2)(B); and
                    ``(C) no more than $5,000,000 is used in each 
                fiscal year to develop advertising material pursuant to 
                subsection (a)(2)(B)(ii).''.

SEC. 505. AUTHORIZATION FOR NATIONAL YOUTH ANTI-DRUG MEDIA CAMPAIGN.

    The Drug-Free Media Campaign Act of 1998 (21 U.S.C. 1801 et seq.) 
is amended by striking sections 104 and 105 and inserting the 
following:

``SEC. 104. AUTHORIZATION OF APPROPRIATIONS.

    ``There is authorized to be appropriated to the Office of National 
Drug Control Policy to carry out this subtitle, $195,000,000 for each 
of the fiscal years 2006 through 2010.''.

       TITLE VI--AUTHORIZATIONS AND EXTENSION OF TERMINATION DATE

SEC. 601. AUTHORIZATION OF APPROPRIATIONS.

    Section 714 is amended--
            (1) by striking ``title,'' and inserting ``title except 
        activities otherwise specified,''; and
            (2) by striking ``1999 through 2003'' and inserting ``2006 
        through 2010''.

SEC. 602. EXTENSION OF TERMINATION DATE.

    Section 715(a) is amended by striking ``September 30, 2003, this 
title and the amendments made by this title'' and inserting ``September 
30, 2010, this title and the amendments made to this title''.

                     TITLE VII--ANTI-DOPING AGENCY

SEC. 701. DESIGNATION OF UNITED STATES ANTI-DOPING AGENCY.

    (a) Definitions.--In this title:
            (1) United states olympic committee.--The term ``United 
        States Olympic Committee'' means the organization established 
        by the ``Ted Stevens Olympic and Amateur Sports Act'' (36 
        U.S.C. 220501 et seq.).
            (2) Amateur athletic competition.--The term ``amateur 
        athletic competition'' means a contest, game, meet, match, 
        tournament, regatta, or other event in which amateur athletes 
        compete (36 U.S.C. 220501(b)(2)).
            (3) Amateur athlete.--The term ``amateur athlete'' means an 
        athlete who meets the eligibility standards established by the 
        national governing body or paralympic sports organization for 
        the sport in which the athlete competes (36 U.S.C. 
        22501(b)(1)).
    (b) In General.--The United States Anti-Doping Agency shall--
            (1) serve as the independent anti-doping organization for 
        the amateur athletic competitions recognized by the United 
        States Olympic Committee;
            (2) ensure that athletes participating in amateur athletic 
        activities recognized by the United States Olympic Committee 
        are prevented from using performance-enhancing drugs;
            (3) implement anti-doping education, research, testing, and 
        adjudication programs to prevent United States Amateur Athletes 
        participating in any activity recognized by the United States 
        Olympic Committee from using performance-enhancing drugs; and
            (4) serve as the United States representative responsible 
        for coordination with other anti-doping organizations 
        coordinating amateur athletic competitions recognized by the 
        United States Olympic Committee to ensure the integrity of 
        athletic competition, the health of the athletes and the 
        prevention of use of performance-enhancing drugs by United 
        States amateur athletes.

SEC. 702. RECORDS, AUDIT, AND REPORT.

    (a) Records.--The United States Anti-Doping Agency shall keep 
correct and complete records of account.
    (b) Report.--The United States Anti-Doping Agency shall submit an 
annual report to Congress which shall include--
            (1) an audit conducted and submitted in accordance with 
        section 10101 of title 36, United States Code; and
            (2) a description of the activities of the agency.

SEC. 703. AUTHORIZATION OF APPROPRIATIONS.

    There are authorized to be appropriated to the United States Anti-
Doping Agency--
            (1) for fiscal year 2007, $9,700,000;
            (2) for fiscal year 2008, $10,300,000;
            (3) for fiscal year 2009, $10,600,000;
            (4) for fiscal year 2010, $11,000,000; and
            (5) for fiscal year 2011, $11,500,000.

                   TITLE VIII--DRUG-FREE COMMUNITIES

SEC. 801. REAUTHORIZATION.

    Section 1024(a) of the Drug-Free Communities Act of 1997 (21 U.S.C. 
1524(a)) is amended--
            (1) in paragraph (9), by striking ``and'' after the 
        semicolon;
            (2) in paragraph (10), by striking the period and inserting 
        a semicolon; and
            (3) by adding at the end the following:
            ``(11) $109,000,000 for fiscal year 2008;
            ``(12) $119,000,000 for fiscal year 2009;
            ``(13) $129,000,000 for fiscal year 2010;
            ``(14) $139,000,000 for fiscal year 2011; and
            ``(15) $149,000,000 for fiscal year 2012.''.

SEC. 802. SUSPENSION OF GRANTS.

    (a) In General.--Section 1032(b) of the Drug-Free Communities Act 
of 1997 (21 U.S.C. 1532(b)) is amended by adding at the end the 
following:
            ``(4) Process for suspension.--A grantee shall not be 
        suspended or terminated under paragraph (1)(A)(ii), 
        (2)(A)(iii), or (3)(E) unless that grantee is afforded a fair, 
        timely, and independent appeal prior to such suspension or 
        termination.''.
    (b) Report to Congress.--Not later than 60 days after the date of 
enactment of this Act, the Director of the Office of National Drug 
Control Policy shall submit to Congress a report detailing the appeals 
process required by section 1032 (b)(4) of the Drug-Free Communities 
Act of 1997, as added by subsection (a).

SEC. 803. GRANT AWARD INCREASE.

    Subsections (b)(1)(A)(iv), (b)(2)(C)(i), and (b)(3)(F) of section 
1032 of the Drug-Free Communities Act of 1997 (21 U.S.C. 1532) are 
amended by striking ``$100,000'' and inserting ``$125,000''.

SEC. 804. PROHIBITION ON ADDITIONAL ELIGIBILITY CRITERIA.

    Section 1032(a) of the Drug-Free Communities Act of 1997 (21 U.S.C. 
1532(a)) is amended by adding at the end the following:
            ``(7) Additional criteria.--The Director shall not impose 
        any eligibility criteria on new applicants or renewal grantees 
        not provided in this chapter.''.

SEC. 805. SUPPLEMENTAL GRANTS FOR COALITIONS.

    The Drug-Free Communities Act of 1997 (21 U.S.C. 1521 et seq.) is 
amended by inserting after section 1035 the following:

``SEC. 1036. SUPPLEMENTAL GRANTS FOR COALITIONS WITH A MAJOR LOCAL DRUG 
              CRISIS.

    ``(a) Authority to Make Grants.--As part of the program established 
under section 1031, the Director may award an initial grant under this 
subsection, and renewal grants under subsection (f), to any coalition 
awarded a grant under section 1032 that meets the criteria specified in 
subsection (d) in order to fund a coalition dealing with a major local 
drug crisis.
    ``(b) Treatment With Other Grants.--
            ``(1) Supplement.--A grant awarded to a coalition under 
        this section is in addition to any grant awarded to the 
        coalition under section 1032.
            ``(2) Requirement for basic grant.--A coalition may not be 
        awarded a grant under this section for a fiscal year unless the 
        coalition was awarded a grant or renewal grant under section 
        1032(b) for that fiscal year.
    ``(c) Application.--A coalition seeking a grant under this section 
shall submit to the Administrator an application for the grant in such 
form and manner as the Administrator may require.
    ``(d) Criteria.--A coalition meets the criteria specified in this 
subsection if the coalition--
            ``(1) has achieved by or through it's own efforts 
        measurable results in the prevention and reduction of substance 
        use among youth generally;
            ``(2) has documented a highly, statistically significant 
        increase in a specific drug, from a baseline determined by 
        locally collected data, that can be defined as a local drug 
        crisis; and
            ``(3) submits to the Administrator a detailed plan for 
        addressing the specific local drug crisis.
    ``(e) Use of Grant Funds.--A coalition awarded a grant under this 
section shall use the grant amount for implementing comprehensive, 
community-wide strategies that address their local drug crises in 
accordance with the detailed plan submitted to the Administrator under 
subsection (d)(3).
    ``(f) Renewal Grants.--The Administrator may make a renewal grant 
to any coalition awarded a grant under subsection (a), or a previous 
renewal grant under this subsection, if the coalition at the time of 
the application for such renewal grant--
            ``(1) continues to meet the criteria specified in 
        subsection (d); and
            ``(2) has made demonstrable progress in addressing the 
        specific local drug crisis.
    ``(g) Grant Amounts.--
            ``(1) In general.--Subject to paragraphs (2) and (3) the 
        total amount of grants awarded to a coalition under this 
        section for a fiscal year may not exceed the amount of non-
        Federal funds raised by the coalition, including in kind 
        contributions, for that fiscal year.
            ``(2) Initial grants.--The amount of the initial grant 
        awarded to a coalition under subsection (a) may not exceed 
        $50,000.
            ``(3) Renewal grants.--The total amount of renewal grants 
        awarded to a coalition under subsection (f) for any fiscal year 
        may not exceed $50,000.
    ``(h) Fiscal Year Limitation on the Amount Available for Grants.--
The total amount available for grants under this section, including 
renewal grants under subsection (f), in any fiscal year may not exceed 
the amount equal to 5 percent of the actual amount appropriated for 
that fiscal year.''.

SEC. 806. NATIONAL COMMUNITY ANTI-DRUG COALITION INSTITUTE.

    Section 4 of Public Law 107-82 (21 U.S.C. 1521 note), reauthorizing 
the Drug-Free Communities Support Program, is amended--
            (1) by amending subsection (a) to read as follows:
    ``(a) In General.--The Director of the Office of National Drug 
Control Policy shall, using amounts authorized to be appropriated by 
subsection (d), make a directed grant to Community Anti-Drug Coalitions 
of America to provide for the continuation of the National Community 
Antidrug Coalition Institute.'';
            (2) by striking subsection (b) and redesignating 
        subsections (c) and (d) as (b) and (c), respectively; and
            (3) in subsection (c), as redesignated by paragraph (2), by 
        adding at the end the following:
            ``(4) For each of the fiscal years 2008 through 2012, 
        $2,000,000.''.

SEC. 807. CONTRACTING REQUIREMENT.

    Section 1031(d) of the Drug-Free Communities Act of 1997 (21 U.S.C. 
1531(d)) is amended by adding at the end the following: ``The Director 
shall delegate all authority for grant eligibility determinations, 
review, selection, management, and appeals to another qualified 
national drug control agency.''.

              TITLE IX--NATIONAL GUARD COUNTERDRUG SCHOOLS

SEC. 901. NATIONAL GUARD COUNTERDRUG SCHOOLS.

    (a) Authority To Operate.--Under such regulations as the Secretary 
of Defense may prescribe, the Chief of the National Guard Bureau may 
establish and operate, or provide financial assistance to the States to 
establish and operate, not more than five schools (to be known 
generally as ``National Guard counterdrug schools'').
    (b) Purpose.--The purpose of the National Guard counterdrug schools 
shall be the provision by the National Guard of training in drug 
interdiction and counterdrug activities and drug demand reduction 
activities to personnel of the following:
            (1) Federal agencies.
            (2) State and local law enforcement agencies.
            (3) Community-based organizations engaged in such 
        activities.
            (4) Other non-Federal governmental and private entities and 
        organizations engaged in such activities.
    (c) Counterdrug Schools Specified.--The National Guard counterdrug 
schools operated under the authority in subsection (a) are as follows:
            (1) The National Interagency Civil-Military Institute 
        (NICI), San Luis Obispo, California.
            (2) The Multi-Jurisdictional Counterdrug Task Force 
        Training (MCTFT), St. Petersburg, Florida.
            (3) The Midwest Counterdrug Training Center (MCTC), 
        Johnston, Iowa.
            (4) The Regional Counterdrug Training Academy (RCTA), 
        Meridian, Mississippi.
            (5) The Northeast Regional Counterdrug Training Center 
        (NCTC), Fort Indiantown Gap, Pennsylvania.
    (d) Use of National Guard Personnel.--
            (1) In general.--To the extent provided for in the State 
        drug interdiction and counterdrug activities plan of a State in 
        which a National Guard counterdrug school is located, personnel 
        of the National Guard of that State who are ordered to perform 
        full-time National Guard duty authorized under section 112(b) 
        of that title 32, United States Code, may provide training 
        referred to in subsection (b) at that school.
            (2) Definition.--In this subsection, the term ``State drug 
        interdiction and counterdrug activities plan'', in the case of 
        a State, means the current plan submitted by the Governor of 
        the State to the Secretary of Defense under section 112 of 
        title 32, United States Code.
    (e) Treatment Under Authority To Provide Counterdrug Support.--The 
provisions of section 1004 of the National Defense Authorization Act 
for Fiscal Year 1991 (Public Law 101-510; 10 U.S.C. 374 note) shall 
apply to any activities of a National Guard counterdrug school under 
this section that are for an agency referred to in subsection (a) of 
such section 1004 and for a purpose set forth in subsection (b) of such 
section 1004.
    (f) Annual Reports on Activities.--
            (1) In general.--Not later than February 1 each year, the 
        Secretary of Defense shall submit to Congress a report on the 
        activities of the National Guard counterdrug schools during the 
        preceding year.
            (2) Contents.--Each report under paragraph (1) shall set 
        forth the following:
                    (A) Funding.--The amount made available for each 
                National Guard counterdrug school during the fiscal 
                year ending in the year preceding the year in which 
                such report is submitted.
                    (B) Activities.--A description of the activities of 
                each National Guard counterdrug school during the year 
                preceding the year in which such report is submitted.
    (g) Authorization of Appropriations.--
            (1) In general.--There is hereby authorized to be 
        appropriated for the Department of Defense for the National 
        Guard for each of fiscal years 2006 through 2010, $30,000,000 
        for purposes of the National Guard counterdrug schools in such 
        fiscal year.
            (2) Construction.--The amount authorized to be appropriated 
        by paragraph (1) for a fiscal year is in addition to any other 
        amount authorized to be appropriated for the Department of 
        Defense for the National Guard for such fiscal year.

TITLE X--NATIONAL METHAMPHETAMINE INFORMATION CLEARINGHOUSE ACT OF 2006

SEC. 1001. SHORT TITLE.

    This title may be cited as the ``National Methamphetamine 
Information Clearinghouse Act of 2006''.

SEC. 1002. DEFINITIONS.

    In this title--
            (1) the term ``Council'' means the National Methamphetamine 
        Advisory Council established under section 1003(b)(1);
            (2) the term ``drug endangered children'' means children 
        whose physical, mental, or emotional health are at risk because 
        of the production, use, or other effects of methamphetamine 
        production or use by another person;
            (3) the term ``National Methamphetamine Information 
        Clearinghouse'' or ``NMIC'' means the information clearinghouse 
        established under section 1003(a); and
            (4) the term ``qualified entity'' means a State or local 
        government, school board, or public health, law enforcement, 
        nonprofit, community antidrug coalition, or other 
        nongovernmental organization providing services related to 
        methamphetamines.

SEC. 1003. ESTABLISHMENT OF CLEARINGHOUSE AND ADVISORY COUNCIL.

    (a) Clearinghouse.--There is established, under the supervision of 
the Attorney General of the United States, an information clearinghouse 
to be known as the National Methamphetamine Information Clearinghouse.
    (b) Advisory Council.--
            (1) In general.--There is established an advisory council 
        to be known as the National Methamphetamine Advisory Council.
            (2) Membership.--The Council shall consist of 10 members 
        appointed by the Attorney General--
                    (A) not fewer than 3 of whom shall be 
                representatives of law enforcement agencies;
                    (B) not fewer than 4 of whom shall be 
                representatives of nongovernmental and nonprofit 
                organizations providing services or training and 
                implementing programs or strategies related to 
                methamphetamines; and
                    (C) 1 of whom shall be a representative of the 
                Department of Health and Human Services.
            (3) Period of appointment; vacancies.--Members shall be 
        appointed for 3 years. Any vacancy in the Council shall not 
        affect its powers, but shall be filled in the same manner as 
        the original appointment.
            (4) Personnel matters.--
                    (A) Travel expenses.--The members of the Council 
                shall be allowed travel expenses, including per diem in 
                lieu of subsistence, at rates authorized for employees 
                of agencies under subchapter I of chapter 57 of title 
                5, United States Code, while away from their homes or 
                regular places of business in the performance of 
                services for the Council.
                    (B) No compensation.--The members of the Council 
                shall not receive compensation for the performance of 
                the duties of a member of the Council.

SEC. 1004. NMIC REQUIREMENTS AND REVIEW.

    (a) In General.--The NMIC shall promote sharing information 
regarding successful law enforcement, treatment, environmental, 
prevention, social services, and other programs related to the 
production, use, or effects of methamphetamine and grants available for 
such programs.
    (b) Components.--The NMIC shall include--
            (1) a toll-free number; and
            (2) a website that provides a searchable database, which--
                    (A) provides information on the short-term and 
                long-term effects of methamphetamine use;
                    (B) provides information regarding methamphetamine 
                treatment and prevention programs and strategies and 
                programs for drug endangered children, including 
                descriptions of successful programs and strategies and 
                contact information for such programs and strategies;
                    (C) provides information regarding grants for 
                methamphetamine-related programs, including contact 
                information and links to websites;
                    (D) allows a qualified entity to submit items to be 
                posted on the website regarding successful public or 
                private programs or other useful information related to 
                the production, use, or effects of methamphetamine;
                    (E) includes a restricted section that may only be 
                accessed by a law enforcement organization that 
                contains successful strategies, training techniques, 
                and other information that the Council determines 
                helpful to law enforcement agency efforts to identify 
                or combat the production, use or effects of 
                methamphetamine;
                    (F) allows public access to all information not in 
                a restricted section; and
                    (G) contains any additional information the Council 
                determines may be useful in identifying or combating 
                the production, use, or effects of methamphetamine.
    (c) Review of Posted Information.--
            (1) In general.--Not later than 30 days after the date of 
        submission of an item by a qualified entity, the Council shall 
        review an item submitted for posting on the website described 
        in subsection (b)(2)--
                    (A) to evaluate and determine whether the item, as 
                submitted or as modified, meets the requirements for 
                posting; and
                    (B) in consultation with the Attorney General, to 
                determine whether the item should be posted in a 
                restricted section of the website.
            (2) Determination.--Not later than 45 days after the date 
        of submission of an item, the Council shall--
                    (A) post the item on the website described in 
                subsection (b)(2); or
                    (B) notify the qualified entity that submitted the 
                item regarding the reason such item shall not be posted 
                and modifications, if any, that the qualified entity 
                may make to allow the item to be posted.

SEC. 1005. AUTHORIZATION OF APPROPRIATIONS.

    There are authorized to be appropriated--
            (1) for fiscal year 2006--
                    (A) $2,000,000 to establish the NMIC and Council; 
                and
                    (B) such sums as are necessary for the operation of 
                the NMIC and Council; and
            (2) for each of fiscal years 2007 through 2010, such sums 
        as are necessary for the operation of the NMIC and Council.

                   TITLE XI--MISCELLANEOUS PROVISIONS

SEC. 1101. REPEALS.

    (a) Act.--Sections 709, 710, and 711 are repealed.
    (b) Forfeiture Assets.--Section 6073 of the Assets Forfeiture 
Amendments Act of 1988 (21 U.S.C. 1509) is repealed.

SEC. 1102. CONTROLLED SUBSTANCES ACT AMENDMENTS.

    Section 303(g)(2)(B)(iii) of the Controlled Substances Act (21 
U.S.C. 823(g)(2)(B)(iii)) is amended by striking ``except that the 
Secretary'' and inserting the following: ``unless, not sooner than 1 
year after the date on which the practitioner submitted the initial 
notification, the practitioner submits a second notification to the 
Secretary of the need and intent of the practitioner to treat more than 
such applicable number of patients. A second notification under this 
clause shall contain the certifications required by clauses (i) and 
(ii) of this subparagraph. The Secretary''.

SEC. 1103. REPORT ON INTELLIGENCE SHARING.

    Not later than 180 days after the date of enactment of this Act, 
the Director shall submit to Congress a report--
            (1) evaluating existing and planned intelligence systems 
        used by Federal, State, and local law enforcement agencies 
        responsible for drug trafficking and drug production 
        enforcement; and
            (2) addressing--
                    (A) the current intelligence systems used by 
                Federal, State, and local law enforcement agencies;
                    (B) the compatibility of such systems in ensuring 
                access and availability of intelligence to Federal, 
                State, and local law enforcement;
                    (C) the extent to which Federal, State, and local 
                law enforcement are sharing intelligence information to 
                assess current threats and design appropriate 
                enforcement strategies; and
                    (D) the measures needed to ensure and to promote 
                effective information sharing among intelligence 
                systems operated by Federal, State, and local law 
                enforcement agencies responsible for drug trafficking 
                and drug production enforcement.

SEC. 1104. REQUIREMENT FOR SOUTH AMERICAN HEROIN STRATEGY.

    (a) In General.--Not later than 90 days after the date of enactment 
of this Act, the Director shall submit to Congress a comprehensive 
strategy that addresses the increased threat from South American 
heroin, and in particular Colombian heroin, and the emerging threat 
from opium poppy grown in Peru and often intended for transit to 
Columbia for processing into heroin.
    (b) Contents.--The strategy submitted under subsection (a) shall 
include--
            (1) opium eradication efforts to eliminate the problem at 
        the source to prevent heroin from entering the stream of 
        commerce;
            (2) interdiction and precursor chemical controls;
            (3) demand reduction and treatment;
            (4) alternative development programs, including direct 
        assistance to regional governments to demobilize and provide 
        alternative livelihoods to former members of insurgent or other 
        groups engaged in heroin, cocoa, or other illicit drug 
        production or trafficking;
            (5) efforts to inform and involve local citizens in the 
        programs described in paragraphs (1) through (4), such as 
        through leaflets advertising rewards for information;
            (6) provisions that ensure the maintenance at current 
        levels of efforts to eradicate coca in Colombia; and
            (7) an assessment of the specific level of funding and 
        resources necessary to simultaneously address the threat from 
        South American heroin and the threat from Colombian and 
        Peruvian coca.
    (c) Treatment of Classified or Law Enforcement Sensitive 
Information.--Any content of the strategy submitted under subsection 
(a) that involves information classified under criteria established by 
an Executive order, or whose public disclosure, as determined by the 
Director or the head of any relevant Federal agency, would be 
detrimental to the law enforcement of national security activities of 
any Federal, foreign, or international agency, shall be presented to 
Congress separately from the rest of the strategy.

SEC. 1105. MODEL ACTS.

    (a) In General.--The Director shall enter into an agreement with a 
nonprofit corporation that works with States on laws and policies to 
address alcohol and other drug issues, under which the corporation 
shall revise the model State drug laws developed by the President's 
Commission on Model State Drug Laws and draft supplementary model acts 
to meet changes in States' substance abuse issues.
    (b) Authorization of Appropriations.--There are authorized to be 
appropriated $1,500,000 to carry out this section.

SEC. 1106. STUDY ON IATROGENIC ADDICTION ASSOCIATED WITH PRESCRIPTION 
              OPIOID ANALGESIC DRUGS.

    (a) In General.--
            (1) Study.--The Director of the Office of National Drug 
        Control Policy shall request the Institute of Medicine of the 
        National Academy of Sciences to enter into an agreement under 
        which the Institute agrees to study certain aspects of 
        iatrogenic addiction to prescription opioid analgesics included 
        in schedules II and III of the Controlled Substances Act (21 
        U.S.C. 812).
            (2) Iatrogenic addiction.--In this section, the term 
        ``iatrogenic addiction'' means an addiction developed from the 
        use of an opioid analgesic by an individual with no previous 
        history of any addiction, who has lawfully obtained and used 
        the drug for a legitimate medical purpose by administration 
        from, or pursuant to the prescription or order of, an 
        individual practitioner acting in the usual course of 
        professional practice.
    (b) Requirements.--The study conducted pursuant to this section 
shall assess the current scientific literature to determine, if 
possible--
            (1) the rate of iatrogenic addiction associated with the 
        appropriate use of prescription drugs described in subsection 
        (a);
            (2) the impact of iatrogenic addiction associated with the 
        appropriate use of prescription drugs described in subsection 
        (a) on the individual, the prescriber, other patients, and 
        society in general;
            (3) the comparative abuse liability of prescription drugs 
        described in subsection (a) when used properly by the ultimate 
        user for a legitimate medical purpose; and
            (4)(A) what types of prospective or retrospective studies 
        should be undertaken to determine the rate of iatrogenic 
        addiction associated with the appropriate use of the 
        prescription drugs described in subsection (a); and
            (B) a feasible timeline for conducting and reporting such 
        studies, should the current state of the scientific literature 
        be insufficient to determine the rate, impact, and comparative 
        abuse liability of prescription drugs described in subsection 
        (a).
    (c) Report.--Not later than 1 year after the date of enactment of 
this Act, the Director of the Office of National Drug Control Policy 
shall ensure that the agreement under subsection (a) provides for the 
submission of a report to the Congress on the status of the study 
conducted pursuant to this section.

SEC. 1107. REQUIREMENT FOR STRATEGY TO STOP INTERNET ADVERTISING OF 
              PRESCRIPTION MEDICINES WITHOUT A PRESCRIPTION.

    Not later than 120 days after the date of the enactment of this 
Act, the Director of the Office of National Drug Control Policy shall 
submit to Congress a strategy to stop advertisements that provide 
information about obtaining over the Internet drugs (as defined in 
section 702(3) of the Office of National Drug Control Policy 
Reauthorization Act of 1998) for which a prescription is required 
without the use of such a lawful prescription.

SEC. 1108. REQUIREMENT FOR STUDY ON DIVERSION AND INAPPROPRIATE USES OF 
              PRESCRIPTION DRUGS.

    Not later than 90 days after the date of enactment of this Act, the 
Director of the Office of National Drug Control Policy, in consultation 
with the Secretary of Health and Human Services, shall submit to 
Congress a report that includes a plan to conduct a study on the 
illegal diversion and inappropriate uses of prescription drugs, 
including the following:
            (1) Methods to utilize both public use surveys that are in 
        existence as of the date of enactment of this Act and other 
        surveys to provide appropriate baseline data on the natural 
        history of diversion and abuse of prescription drugs that are 
        included in schedules under the Controlled Substances Act to 
        evaluate the extent and nature of potential problems with such 
        use to guide corrective actions which may reduce such problems 
        without unintentionally hindering access to these drugs for 
        legitimate medical purposes. Specifically, other surveys to be 
        considered are those that address the abuse of these substances 
        on a regional or national basis, and those that address the 
        diversion of these substances on a regional or national basis.
            (2) A scientifically based analysis of the relative 
        contribution of both innate and acquired genetic factors, 
        environmental factors, psychological factors and drug 
        characteristics that contribute to addiction to prescription 
        drugs.
                                                       Calendar No. 452

109th CONGRESS

  2d Session

                                S. 2560

_______________________________________________________________________

                                 A BILL

       To reauthorize the Office of National Drug Control Policy.

_______________________________________________________________________

                              May 25, 2006

                       Reported with an amendment